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ABSTRACT 
Billions of dollars are spent on diabetes in healthcare each year.  Patients with lower socio-
economic-status tend to have poor glycemic control, higher associated diabetic complications, 
and higher associated mortality rates.  In underserved patients with Type 2 Diabetes, does 
utilization of a Diabetes app, compared to previous self-care management and clinic education, 
lower the Hemoglobin A1c over a 3-month period?  A 3-month scholarly project was conducted 
in a small rural town in Virginia with an average median income around $17,000.  N=21 
participants were selected for the scholarly project.  Inclusive criteria consisted of adults aged 
19-70 years with a diagnosis of type 2 diabetes for more than 6 months.  Participants were 
required to have access to iOS/Android cellular devices.  Additionally, participants were 
requested to complete pre and post self-care management and demographics questionnaires, and 
utilize the Diabetes app daily during the 3 month intervention window.  After the 3-month 
intervention window, particpants had an overall decrease in hemoglobin A1c by (2.34%, p = 
.004).  Further evidence demonstrated a direct improvement in self-care management techniques 
ratings based on average, good, and great with an overall mean increase of 14.3% after the 
intervention window.  Particpants who scored poor and bad had an overall mean decrease of 
21.38% after the intervention period.  Mobile-based technology serves to help patients achieve 
their target glycemic goals, reduce mortality and morbidity, and promotes more versatile 
methods of healthcare delivery compared to traditional interventions and educational methods 
such as oral glycemic agents, diabetic class education, and insulin administration to manage 
T2DM.   
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SECTION ONE: INTRODUCTION 
Each year, 327 billion dollars are spent on diabetes in healthcare (American Diabetes 
Association [ADA], 2018).  Currently, over 30 million people live with Diabetes Mellitus Type 2 
(T2DM) in the United States (ADA, 2018).  Unfortunately, patients suffering from diabetes often 
are non-compliant with recommended medical therapies.  Adherence is defined as a person’s 
ability to take medication, follow recommended dietary modifications, lifestyle modifications, 
and retain close communication between the provider and patient (Perez, Alvarez, Dilla, & 
Guillen, 2013).  Despite supportive evidence that demonstrates increased compliance and 
longevity of patients suffering from T2DM with medication compliance, around 50% of patients 
with T2DM are non-complaint with associated medical therapies (Perez et al., 2013).  As a 
result, hyperglycemia and increased mortality leads to billions of dollars in healthcare services 
spent each year (Perez et al., 2013). 
Poverty is not only associated with a higher incident of diabetes, it is also associated with 
decreased access to diabetic management (Hsu et al., 2012).  Patients with low socio-economic-
status tend to have poor glycemic control, higher associated diabetes complications, and higher 
mortality rates (Hsu et al., 2012).  Various barriers to optimizing care of patients suffering from 
T2DM in low-income areas include lack of transportation, limited healthcare access, and medical 
costs associated with medical supplies (Hsu et al., 2012).  People of low socio-economic status 
are more than 50% less likely to receive recommended diabetic checkups (Hsu et al., 2012). 
What can be done to solve this problem in the underserved population?  How can we 
decrease the unequal disparities associated with T2DM in poor communities compared to middle 
and high-income class communities?  Two of the most commonly associated barriers to effective 
management of T2DM are a lack of communication between the patient and provider and failed 
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follow-up appointments.  Is there a way to help correct this problem?  We currently live in a 
technological era.  In particular, smartphone and devices with mobile app capabilities can be 
used to help patients manage chronic illnesses.  The vast majority of Americans own cell phones, 
accounting for approximately 96% of the United States population (“Cell Phone Facts,” 2019).  
Of people with cell phones 81% have smartphone capabilities (“Cell Phone Facts,” 2019).   
Whitehead and Seaton (2016) reviewed several studies supporting the usage of mobile apps to 
improve symptom management and compliance through self-care management interventions.  
The purpose of this scholarly project was to determine if the utilization of the Diabetes app 
would decrease the hemoglobin A1c and improve the self-care management techniques in 
patients diagnosed with T2DM in the underserved patient population.  
Background 
Working with the underserved population can serve as a difficult challenge.  The 
underserved population often have several barriers to face with healthcare.  Pulmonary, 
cardiovascular, learning disabilities, and poor quality of life are common health disparities within 
the underserved population (Hooker, 2013).  Diabetes management in the underserved patient 
population is disproportionately managed compared to higher socioeconomic classes.  In fact, 
compliance and treatment failure rates are higher within the underserved patient population 
(Hooker, 2013).  This unfortunate fact applies to those who suffer from T2DM.  What if there 
was a way to help bridge this gap in healthcare and avoid this barrier to optimizing care?  
Technological advancements have provided revolutionary advancements in medicine.  How can 
mobile-based technology be utilized to facilitate better healthcare management for the 
underserved patient population? 
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T2DM requires extensive self-care management techniques for effective disease 
management (Beverly, Worley, Court, Prokopakis, & Ivanov, 2016).  Fundamentally, effective 
communication between patients and providers must consist of continuous care (Beverly et al., 
2016).  Recent studies reflect that diabetic self-care communication is directly related to patient 
satisfaction, medication compliance, and associated with improved patient outcomes and patient 
satisfaction (Beverly et al., 2016).  Providers often report one of the biggest barriers to effective 
communication with patients is time limitations (Beverly et al., 2016).  Interestingly, a recent 
study concluded that patients felt shame, guilt, and even embarrassment to report they did not 
feel connected with their providers during and after chronic care appointments due to time 
constraints (Beverly et al., 2016).  However, one benefit of utilizing the Diabetes app was to 
break down barriers and optimize effective patient provider communication while improving 
participants self-care management techniques for T2DM.   
Utilization of the Diabetes app served to improve communication between patients and 
providers outside of traditional chronic care visits.  An educational hub for patients in the 
underserved patient population.  It consisted of dietary food options, various exercise regimens, 
blood sugar log, diabetic education congruent with the American Diabetes Association (ADA), 
and self-care techniques for diabetes management.  Increased self-care management techniques 
should improve patients’ hemoglobin A1c outside of traditional T2DM chronic care 
management.  Recent studies supported that even small improvements in patient–provider 
communication positively influence self-care adherence for patients with T2DM (Patel, Datye, & 
Jesser, 2018). 
Lately, technology has transformed the way healthcare is delivered to patients with 
T2DM.  Technological advancements in the management of T2DM include accurate data 
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collection and tracking, online glucose monitoring, improved glucometers, improvement of 
diabetic insulin pumps, improvement of access to health information, streaming information 
monitors, and a complete expansion of innovative therapies available for patients in the forms of 
oral glycemic agents and various insulins.  Technology has served as an excellent reservoir for 
improving self-care management techniques in patients with T2DM.  Technology improves the 
self-care management techniques of patients by enabling patients to perform self-blood glucose 
monitoring, dietary adherence recommendations, medication adherence, and user platform 
discussion forums.  The utilization of mobile-based app technology improves barriers to 
healthcare access, enhances patient education, and increases patient exposure to self-care 
management techniques.  Healthcare providers should incorporate the utilization of mobile-based 
technology to effectively manage T2DM.          
Problem Statement  
Research supports that the underserved patient population suffers increased mortality and 
morbidity by more than 50% compared to middle- and high-income groups who suffer from 
T2DM (Duke, Colaguri, & Colaguri, 2015).  Often, the underserved patient population reports a 
lack of transportation, limited healthcare access, and a lack of self-care management techniques 
as barriers to effectively managing their chronic illnesses.  This rural clinic located in Virginia 
experiences many of these barriers resulting in decreased self-care management compliance and 
unchanged hemoglobin A1c levels.  
Purpose of the Project 
The purpose of this scholarly project was to determine if utilization of the Diabetes app 
would decrease the hemoglobin A1c in patients diagnosed with T2DM in the underserved patient 
population and enhance their self-care management techniques.  Additionally, the project aimed 
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to provide the underserved patient population with full-time access to various educational 
resources to improve self-care management techniques.   
Clinical Question  
In underserved patients with T2DM, does utilization of a Diabetes App, compared to 
previous self-care management and clinic education, lower the hemoglobin A1c over a three-
month period? 
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SECTION TWO: LITERATURE REVIEW 
The purpose of this literature review was to provide insight into the health disparities 
within the underserved population with T2DM.  This literature review explored the benefits of 
utilizing mobile apps to improve self-care management of patients with T2DM resulting in 
decreased hemoglobin A1c.  Qualitative and quantitative research provided evidence to support 
the utilization of mobile apps associated with the clinical management of T2DM.  This literature 
review evaluated the influence of mobile-based technology and patient self-care management 
techniques of T2DM.   
Search Strategy  
A literature review was conducted to gather data pertaining to the large healthcare 
disparity among diabetics within the underserved patient population.  Goals of the search set out 
to optimize the most relevant data supporting the utilization of mobile-based technology and 
diabetic management.  A comprehensive database search was conducted using CINAHL, 
Pubmed, Medline, and EBSCOhost, and ProQuest.  The following keywords and phrases were 
utilized during the search: mobile app help manage diabetes, mobile technology effectively 
manage chronic illnesses, mobile technology decreases hemoglobin A1c, barriers in underserved 
patient populations diabetes management, barriers underserved population healthcare, and 
mobile app devices assist healthcare providers to optimize care.  Parameters of the literature 
search included peer-reviewed studies, clinical case studies, and clinical trials written in the 
English language within the past 5 years.  The total number of articles reviewed before 
application of parameters applied was 40.  After inclusion criteria was applied there were 20 
remaining articles.  Careful attention was taken during this literature search to avoid biased work, 
ineffective data, and research studies that contained conflicts of interest.   
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Critical Appraisal  
Each article was examined for the level of evidence according to Melnyk’s system of 
hierarchy (Research Guides, 2015).  The articles included in this scholarly project’s literature 
review included three cross sectional design studies, five randomized controlled trials, seven 
non-randomized control trials, and five systematic reviews.  The remaining articles varied from 
levels of evidence I-IV, including quasi-experimental and randomized control trials.  The quality 
of each study is provided in Appendix A.   
Systematic reviews.  A systematic review was conducted in 2016 to evaluate the 
utilization of mobile phones and tablets for self-care management in long term conditions.  An 
extensive web search was conducted via PubMed, Embase, EBSCO database, Cochrane library, 
and the Joanna Briggs Institute Library (Whitehead & Seaton, 2016).  The search consisted of 
randomized control trials consisting of mobile-based technology that utilized mobile apps and 
tablets for self-care management for T2DM, chronic lung disease, and cardiovascular disease 
between 2005-2016 (Whitehead & Seaton, 2016).  Nine studies were evaluated and reviewed for 
this study.  Six of those studies demonstrated statistical relevance and improvement in overall 
clinical outcomes (Whitehead & Seaton, 2016).  Three apps included interventions via the 
utilization of mobile apps and demonstrated statistically significant improvement (Whitehead & 
Seaton, 2016).  Most interventions involved chronic care management of T2DM (5/9) studies 
(Whitehead & Seaton, 2016).  The duration of most interventions ranged from six weeks to one 
year, with follow-up data from the various studies ranging from three months to one year 
(Whitehead & Seaton, 2016).  The number of study participants ranged from 48 to 288 
individuals in the nine studies reviewed (Whitehead & Seaton, 2016). 
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Findings from the systematic review supported the utilization of mobile apps to improve 
symptom management and self-care management interventions (Whitehead & Seaton, 2016).  
Utilization of mobile apps, such as iHealth, amongst those with chronic health issues displayed 
more significant improvement in symptom management (Whitehead & Seaton, 2016).  
Whitehead and Seaton (2016) encouraged further study evaluation to optimize the utilization of 
mobile apps incorporated in chronic disease care management.  Mobile app interventions provide 
innovative ways to optimize the treatment of chronic care conditions (Whitehead & Seaton, 
2016).      
Randomized control trials.  Recently, a randomized control trial by Garg, Shah, Aturk, 
Benson, and Benergeon in 2017 supported the utilization of mobile-based technology in the 
treatment of patients with diabetes.  This randomized control trial consisted of N=100 compared 
to a control group using self-monitoring blood glucose with Accu Check Nano synched with 
iPhone.  All subjects had similar clinic and phone visits for three months, with an extension of 
three months for those utilizing the app.  Participants within the study were required to have at 
least eight visits during the designated study period (Garg et al., 2017).  The goal of Garg et al.’s 
research was to find out if utilization of the Accu Check Nano app would help decrease fear of 
hypoglycemia, worry, and behavior sub-scores.   
Garg et al. (2017) conducted a-six-month study utilizing the two groups with and without 
the utilization of the Accu Check Nano synched app.  At baseline, both groups had similar 
glycosylated hemoglobin A1c values.  However, at six months the intervention group had a 
significant decrease in the hemoglobin A1c compared to the control group, who did not use the 
Accu Check Nano app. (-.16 vs. -.51, p = 0.04) (Garg et al., 2017).  Hypoglycemia fear and 
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behavior scores of the control group were higher compared to the intervention group with no 
increased risk of hypoglycemia (-1.4 ± 10.0 vs. -3.9 ± 12.5, p= 0.32) (Garg et al., 2017).   
Limitations to Garg et al.’s (2017) study consisted of a short-term period (six months) in 
one facility.  In addition, the focus was geared toward only hypoglycemia risk without analyzing 
other blood glucose variabilities (Garg et al., 2017). A strength of Garg et al.’s study was the 
additional data produced that support the utilization of mobile app technology incorporated with 
traditional diabetic management.  Overall results from Garg et al.’s trial indicated that utilization 
of the app with self-glucose monitoring improved diabetic management over a short period of 
time. 
In 2016, Goyal et al. conducted another randomized controlled trial that demonstrated the 
ability of mobile app technology to improve diabetic self-management.  The purpose of Goyal et 
al.’s study was to see if utilization of a mobile app could facilitate and improve self-monitoring, 
self-knowledge skills, and elicit positive behavior changes through effective self-management 
skills of diabetes.  The mobile app consisted of various functions geared toward improving better 
self-care management of patients with diabetes.  Functions included a daily step counter, dietary 
menus, and incentive game with rewards.  Each function within the mobile app supported ways 
the patient could increase their self-improvement behaviors aimed towards better management of 
the chronic disease.  A strength of the mobile app was the structure it provided for participants. 
Self-monitoring glucose reminders for N = 483 reduced their hemoglobin A1c on average 
by 1.2%, compared to the control group utilizing traditional diabetic education methods of (0.4 
to 0.6) (Goyal et al., 2016).  In this study utilization of a game feature within the app improved 
self-glucose measurements by an estimated 49.6% over a 12-week pilot. (Goyal et al., 2016).  A 
limitation of Goyal et al.’s (2016) study was the long-term sustainability of providing incentives 
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to patients.  Goyal et al.’s study reinforced that mobile apps serve as a wonderful complementary 
tool with traditional diabetic education and improvement of self-care management techniques for 
patients with T2DM. 
Non-randomized control trials.  In a non-randomized control trial in Singapore, Goh, 
Tan, Chaun, and Uma (2015) developed an app called interactive diet and activity tracker 
(iDAT) for use among patients with T2DM in various primary care settings.  The objective was 
to predict trajectories of app usage for disease management and to improve self-care 
management of patients with T2DM (Goh et al., 2015).  Goh et al. selected 84 participants who 
had not previously had exposure to the iDAT app.  Goh et al. divided participants into three 
groups: minimal users (78.6%) with no previous iDAT usage; intermittent waning users (11.9%) 
with occasional weekly usage during the first four weeks; and consistent users (9.5%) with 
weekly usage.  Goh et al. studied participants for app usage during an eight-week period.  Most 
participants were android users, accounting for approximately 70% (Goh et al., 2015).  
Interestingly, most users reported strong utilization of their smartphone, with 87% reporting 
using their smartphone more than five times per day (Goh et al., 2015).   
After educational sessions on how to operate the iDAT app, users gave the app an 
average rating score of 6 out of 9 on a 9-point scale (Goh et al., 2015).  Participants who had 
higher associated app usage reported increased levels of exercise.  Results from Goh et al.’s 
(2015) study supported mobile app technology as an excellent complementary tool for providers 
to use to aid in the improvement of self-care management.  Limitations to Goh et al.’s study 
included mobile app data only available on a weekly basis.  In addition, utilization of this app 
only had a marginal usage rate of 3 to 4 out of every 10 users.  Sample size for the study was 
limited and could not effectively represent enough data for larger generalization.  A strength of 
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this study is the realistic feedback based on users’ mobile device app usage for similar studies in 
the future (Goh et al., 2015).  Goh et al. provided more realistic results of what could be seen 
with self-motivation when compared with other popular mobile device apps.  
Cross-sectional studies.  Two cross-sectional design studies revealed a significant 
correlation between self-knowledge of diabetes and improved hemoglobin A1c.  Yang et al., 
(2016) conducted the first cross-sectional study in various regions of China (Western, Eastern, 
and Mainland) with a total of 5,957 participants.  Yang et al. utilized an implemented pre and 
post survey to evaluate self-care improvement measures for T2DM post utilization over a 12-
month period.  After the 12-month period Yang et al. evaluated participants via the implemented 
post survey for diabetic knowledge regarding diet, exercise, blood glucose testing, foot care, and 
medication testing.  Yang et al. concluded that patients with good understanding of T2DM 
improved to 72.1% from 46.8% prior to the implemented study.   
Participants with good T2DM understanding had on average significantly lower fasting 
blood glucose (FBG) and two-hour postprandial blood glucose and were more likely to use self-
monitoring blood glucose, exercise techniques, and medications than those who had a poorer 
understanding (Yang et al., 2016).  Patients with better understanding had better associated 
outcomes (P < 0.001) (Yang et al., 2016).  Strengths of Yang et al.’s study included a large 
sample population, a variety of patient demographics, and extensive study length.  All presented 
data within the data had a P value less than P < 0.005 for significant relevance (Yang et al., 
2016).  Weaknesses of Yang et al.’s study included the number of language dialects among 
various regions and educational levels of sampled regions. 
Synthesis 
T2DM health disparities are common within various types of healthcare systems around 
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the globe.  Common barriers to effective T2DM management can be linked to patient behaviors, 
access to healthcare, insufficient patient education, poor communication between providers and 
patients, and inconsistent patient education.  In a study conducted in 2017, Vencio et al. collected 
data across various regions including Brazil, India, Japan, Spain, UK, and USA to identify 
barriers to effective self-care management of T2DM.  Interestingly, Vencio et al. reported that 
diabetic education covered during traditional chronic care consultations across the various global 
regions was the same.  Diabetic education included healthy dietary intake, frequent exercise 
regimen, and glycemic regulation regarding disease progression and management from most 
providers (Vencio et al., 2017).  Out of 1000 providers surveyed during this study, a common 
reported issue amongst providers is that they wish they had more time at the beside with patients 
to discuss effective self-care disease management techniques (Vencio et al., 2017).  Importantly, 
Vencio et al. provided substantial evidence that supports a disparity between what physicians 
report they included in educational sessions versus what patients can remember during and after 
those sessions for later recall.  Vencio et al. noted education outside of traditional chronic care 
appointments is vital and should be explored to optimize outcomes of patients with T2DM.  
Utilization of mobile apps within clinical practice.   There is a direct relationship 
between the utilization of mobile apps and various positive effects on patients’ self-care 
behaviors.  Mobile-based app technology can be utilized in clinical practice to improve self-care 
management of patients with T2DM.  For instance, Schmocker, Zwahlen, and Denecke (2018) 
implemented the usage of the diabetic app GlucoMan to help encourage self-care management of 
patients with diabetes.  Schmocker et al. encouraged patients over a six-month period to utilize 
the app for blood glucose entry, diabetes information, and food tracking.  The GlucoMan app 
was found to improve patients’ ability to monitor their disease and empower better self-care 
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management of diabetes for their health (Schmocker et al., 2018).  Furthermore, the GlucoMan 
app empowered patients to keep better track of their chronic illness.   
Boyle, Grainger, Hall, and Krebs (2017) conducted research in New Zealand at an 
outpatient clinic examined utilization of a diabetic apps in clinical practice to help improve self-
care management of patients with T2DM.  Boyle et al. found that mobile app users were most 
interested in mobile app functions such as an insulin dose calculator, diabetic diary, blood 
glucose monitoring, and dietary carbohydrate.  As evidenced by 200 implemented surveys, 
patients were interested in learning how to utilize mobile apps to manage their chronic conditions 
(Boyle et al., 2017). 
Mobile app utilization in diabetic management.  Studies were conducted to explore 
various ways to optimize care for patients with T2DM.  Ye, Khan, and Boren (2018) conducted a 
study in China in which they reviewed various apps within the two biggest app platforms 
available (iTunes and Google Play).  Ye et al. interviewed six diabetic educators to examine the 
efficiency of various app functionalities.  Over 1050 mobile apps were reviewed for this study 
(Ye et al., 2018).  Mobile apps were reviewed applying the following criteria: functionality 
within the clinical setting, user preferences, American Association of Diabetic Educators (AAED 
7) criteria of healthy eating, physical activity, glucose monitoring, taking medication, problem 
solving, healthy coping, and reducing risks (Ye et al., 2018).  After inclusive criteria was applied 
a remaining 310 mobile apps were selected for clinical usage in this study (Ye et al., 2018).  Key 
features of these apps consisted of empowering healthy eating, mediation adherence, daily 
exercising, and disease monitoring (Ye et al., 2018).  Exploration of the various apps found that 
mobile technology served as an excellent complementary service to optimize patient outcomes 
associated with T2DM.  Recommendations for future diabetic apps encouraged the inclusion of 
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more evidence-based guidelines to increase further self-care management of diabetes (Ye et al., 
2018).   
Mobile-based technology has the power to reach all age groups, various patient 
demographics, and has endless potential for patients with T2DM.  Arnold, Solz, Quade, and 
Kirch (2014) conducted a systematic review examining 656 mobile apps’ functionality to 
determine if they could serve the needs of T2DM patients aged 50 years or older by expert app 
usage.  Arnold et al. noted a large variety of user capabilities within the various mobile apps.  Of 
user apps only 54.1% offered one simple function for end users, while 53% of the apps provided 
a documentation function within the app (Arnold et al., 2014).  The predominant language within 
all examined apps was English (Arnold et al., 2014).  Arnold et al. identified patients as the main 
end user group for all the various apps.  Interestingly, Arnold et al. identified no clear user 
preference between free and paid apps.   
Arnold et al. (2014) utilized a comprehension scale to grade various components within 
the various apps.  Scores generated from the comprehension scale represent app users’ ability to 
navigate and understand overall app functions.  Scores on the comprehension scale are ranked 
from 0-5 with 0 as not able to use at all, 1 as extremely difficult to navigate and use app, 2 as 
somewhat difficult to utilize the app, 3 as fair amount of difficulty utilizing the app, 4 as good 
functionality within the app, and 5 as exceptional ease of app utilization.  On average, most apps 
scored a 4.0 out of 5.0 on the comprehension scale (Arnold et al., 2014).  Arnold et al. reported 
diabetic apps were effective interventional tools to promote self-care management tools for users 
at or over the age of 50 years.  Furthermore, Arnold et al. suggested that the target population is 
well represented utilizing the mobile-based app technology.  Arnold et al.’s results encourage 
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providers to take a proactive stance in the incorporation of alternative complementary tools to 
help improve self-care management associated with T2DM.    
Utilization of mobile apps in underserved patient populations.  Research reflects huge 
disparities in healthcare for patients residing in rural communities.  In order to effectively 
address barriers for those at a disadvantage, healthcare providers must find ways to treat patients 
outside of traditional diabetic educational methods.  In 2015, Shadid, Mahar, Shaikh, and Shaikh 
conducted a study in rural Pakistan consisting of 440 participants and a control group enrolled in 
a randomized control trial study).  The purpose of the study was to establish if mobile app 
technology in a rural community for patients with T2DM would positively influence patient’s 
hemoglobin A1c (Shadid et al., 2015).  The mobile app sent reminders to patients every 15 days 
during the 4-month study period (Shadid et al., 2015).  Shadid et al. revealed participants who 
utilized the mobile app had an increase from baseline in dietary planning from 17.3% to 43.6% 
post mobile app intervention compared to the control group of 13.6% to 15.9%.  Additionally, 
participants showed a direct correlation with their hemoglobin A1c decrease of (RR= 2.71, 95% 
CI=1.18-6.40) during the 4-month period.  All participants compared to the control group had a 
significant positive association with an improved hemoglobin A1c (Shadid et al., 2015).  Results 
within this rural community reinforced the value of managing patients T2DM outside of 
traditional means who have lack of access to healthcare, limited transportation, and have mobile 
technology available. 
Mallow, Theeke, Barnes, Whetsel, and Mallow (2014) conducted an extensive integrated 
review of mobile health supporting the utilization of mobile app technology to improve T2DM 
care within rural community settings.  A trigger for this integrated review was the critical need 
for an effective intervention to help patients with T2DM in rural communities who face 
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commonly associated barriers of rural healthcare (Mallow et al., 2014).  Those barriers identified 
include lack of access to healthcare, poor outcomes of patients within rural communities, and 
lack of provider interventions (Mallow et al., 2014).  Mallow et al.’s integrated review consisted 
of evaluating all mobile technologies involved in the improvement of T2DM care.  Mallow et al. 
studied all relevant data within the inclusive criteria of the study from January to mid-August, 
2013, for significant relevance surrounding mobile health technology in rural communities for 
T2DM patients.  Mallow et al. studied a total of 157 articles were reviewed, with 25 articles 
meeting inclusive criteria.  Results from the study supported the utilization of mobile app 
technology to be effective at improving patients with T2DM outcomes, reducing costs to 
patients, and an exceptional way to provide innovative treatment to communities with limited 
resources (Mallow et al., 2014). 
Conceptual Framework 
The conceptual framework utilized for this scholarly project was the Iowa model (Titler 
et al., 2001).  This model is a commonly utilized framework for the implementation of evidence-
based practice.  The Iowa model utilizes seven triggers to effectively promote best evidence-
based practice methods (Doody & Doody, 2012).  The seven main components of the IOWA 
model include: identify triggering issues, state the purpose, form a team, examine the evidence, 
design the practice change, implement the practice change, evaluate and disseminate the results 
(Doody & Doody, 2012).  Permission was provided by the University of Iowa, Department of 
Nursing to utilize the Iowa Model for this scholarly project (see Appendix B).   
Identify triggering issues and state the purpose.  No-show appointments are associated 
with a higher risk of hospitalization for patient suffering from T2DM (Nuti et al., 2013).  Often, 
patients who “no-show” in primary care settings interrupt the ability of providers to provide 
MOBILE-BASED APP FOR TYPE 2 DIABETES MANAGEMENT 26 
consistent treatment (Nuti et al., 2013).  Nuti et al. (2013) found that diabetic patients who did 
not show to appointments displayed an increase of 60% risk for admission to the emergency 
room (ER).   The rural medical facility has a difficult time trying to keep diabetic education 
appointments with patients due to high levels of no-show appointments.   
Another barrier to effective management of diabetic patients within the organization is 
effectively getting patients within the organization to keep diabetic education appointments after 
traditional chronic care checkups.  A trigger for the scholarly project set to explore solutions that 
aid in resolving various barriers to effective self-care management education for patients in the 
underserved patient population suffering from T2DM.  This project site is committed to 
providing health services, promoting health, reducing health risk factors, and increasing access to 
the uninsured and underserved patient population (Rural Health Clinic, 2018).  This scholarly 
project aligned with the clinics mission by seeking to improve patient access in the underserved 
patient population, decreasing risk factors with unmanaged T2DM, and promoting health 
through improved self-care management techniques through utilization of the diabetes app.  
Team development.  Team development for this scholarly project began with 
identification of key stakeholders for this scholarly project.  This project team leader organized a 
project team to effectively provide adequate resources to implement this scholarly project.  This 
team leader helped the team develop clear roles within the project, establish goals, establish 
project team feedback, and develop a scholarly project timeline.  The project team leader and 
scholarly project chair worked collaboratively together to ensure the scholarly project utilized the 
most evidenced-based practice during implementation of this scholarly project.  The team leader 
organized the team and oversaw all aspects of the project including implementation and 
evaluation of this scholarly project.  The scholarly project team members consisted of a scholarly 
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project chair DNP, FNP-C, student DNP, FNP-C, DNP, FNP-BC, MSN, FNP-C, four LPNs, six 
front desk ancillary staff within the selected organization, and a DNP FNP-C to help analyze 
statistical results.    
Examine the evidence.  Evidence retrieval for this scholarly project was conducted by a 
systematic literature review for best evidence-based practices surrounding the care of T2DM 
utilizing mobile app technology.  The lead team member reviewed all literature and discussed 
evidence with all associated scholarly project team members.  Studies consisted of quasi 
experiment, random controlled trials, non-random controlled trials, systematic reviews, and 
cross-sectional design studies.  The team leader utilized the latest SPSS software for effective 
clinical relevance to analyze the evidence after the imposed intervention. 
The team leader examined each article for the level of evidence according to Melnyk’s 
system of hierarchy (Research Guides, 2015).  This scholarly project’s literature review 
consisted of Levels I to III and Level 5 evidence.  Level I evidence consisted of randomized 
control trials and systematic reviews conducted within primary care settings utilizing mobile 
apps to improve self-care management of patients with T2DM.  Level II evidence articles 
consisted of non-randomized control trials and cohort studies.  Level III evidence articles 
consisted of three quasi experimental design studies supporting mobile-based app technology for 
the management of T2DM self-care management.  Level V evidence consisted of observational 
studies that support the utilization of mobile app usage within the primary care setting.  
Design the practice change.  The team leader implemented the standard utilization of 
mobile app technology within the clinic.  Mobile app technology utilization was based on strong 
supporting evidence that consistently demonstrated positive outcomes with the incorporated 
utilization of the Diabetes app for diabetic education for patients with T2DM.  Clinical 
MOBILE-BASED APP FOR TYPE 2 DIABETES MANAGEMENT 28 
guidelines associated with the utilization of mobile-based app technology served the purpose to 
assist providers and promote better clinical decision-making skills for self-care management of 
T2DM.  Evidence composed from the systematic literature review and similar studies helped 
guide and develop evidence-based practices currently being provided to patients of similar 
demographics and illnesses.  Utilization of mobile-based apps within clinical practices has 
produced substantial evidence of the positive impacts on patient outcomes.  In a growing 
technological era, mobile-based app technology can enhance the ability of providers to improve 
self-care management of T2DM.  Furthermore, the benefits of mobile apps and diabetes 
management can break previous barriers associated with self-care management of T2DM within 
the underserved patient populations.  This scholarly project aimed to provide substantial 
evidence that mobile app-based technology utilization incorporated into diabetic management 
can produce reproducible results and can be effective within the target population.  
Practice change implementation.  One of the biggest challenges throughout healthcare 
remains to be consistent effective implementation of the best evidence-based practices.  The 
scholarly project team leader demonstrated in order to effectively implement new standards 
within an organization, there must be an understanding of organizational culture, a defined 
process, a plan for effective implementation, and a provided effective evaluation (Cullen & 
Adams, 2013).  The scholarly project team leader utilized five steps to help with the 
implementation of this evidence-based practice utilizing mobile-based app technology for 
improved self-care management of T2DM.  The five steps included: create awareness and 
interest within the organization; build knowledge and commitment from all key stakeholders; 
promote action and adoption via educational outreach and multidisciplinary team discussions; 
pursue integration; and sustain use via evaluated results (Cullen & Adams, 2013). 
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The scholarly project team leader started with the developmental process of the mobile 
app with a software company named Appy Pie.  The Diabetes app served as a “one stop shop” 
education hub for patients with T2DM, available on both Android and iOS platforms.  The app 
consisted of several recommended ADA dietary changes, a built-in blood sugar log, healthy 
exercise videos, a variety of meal plans, diabetic education in congruence with ADA 
recommendations, various self-care management techniques, and a frequently-asked-questions 
section.   
This project team leader aimed to recruit 60 established rural health clinic patients who 
met inclusive criteria for the scholarly project.  Concluding the study, participants with the 
highest mobile app utilization and lowest hemoglobin A1c decrease were entered in a raffle 
drawing to win a 19-inch television.  Prior to implementation all participants were provided a pre 
and post diabetic questionnaire-based utilization of the mobile app and assessment of various 
self-care management techniques.  All participants were requested to download the mobile app 
and utilize the Diabetes app daily during the three-month intervention period.  During the three-
month period participants received two push notifications daily and received new downloadable 
content weekly.  All activity within the app was measured daily via google analytics for each 
specific end user.  The purpose for the change in practice was designed to break barriers 
involving ineffective T2DM self-care management within the underserved patient population.  
Evaluation and dissemination the results.  Data-driven decision making and 
incorporation of feedback from all essential stakeholders drove the vitality of this scholarly 
project.  Careful evaluation of p value, overall hemoglobin A1c response, and impact on self-
care management influenced the level of significance and future usage of the mobile app.  
Personal feedback from participants allowed for further engagement needs for future app users, 
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barriers to utilization, and strengths associated with the mobile app.  Data was compared to prior 
hemoglobin A1c levels for comparison purposes with traditional diabetic education and self-
learning alone.   
Results were distributed to participating scholarly project team members during the post-
implementation and evaluation meeting.  Furthermore, at this meeting the team discussed various 
aspects of the conducted project and set the building blocks for the dissemination plan associated 
with this scholarly project.  Other members and staff associated with the organization were 
provided a summary book, with the potential for an article or poster presentation with scholarly 
project results.   
Summary 
The purpose of this literature review was to discover evidence-based practice strategies 
for management of T2DM in underserved and uninsured populations.  Evidence indicated mobile 
apps improve symptom management through improved self-care management (Whitehead & 
Seaton, 2016).  In the current advanced technological era, utilization of mobile apps grants 
healthcare providers another effective tool to encourage self-management of chronic illnesses. 
The critical appraisal of data provided strong evidence for utilization of mobile apps within 
clinical practice, mobile app utilization in diabetic management, and utilization of mobile apps in 
underserved populations.  DNPs have the knowledge and skills to work in collaboration with 
software designers to help develop these apps for specific chronic illnesses.  Literature supported 
the need for this scholarly project, which was to decrease the hemoglobin A1c in patients with 
T2DM by utilizing a mobile app to improve self-care management.   
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SECTION THREE: METHODOLOGY  
Design 
The purpose of this scholarly project was to determine if the utilization of a Diabetes app 
would decrease the hemoglobin A1c and improve the self-care management of patients 
diagnosed with T2DM in the underserved patient population.  The Diabetes app aimed to provide 
the underserved patient population full-time access to improved self-care management 
techniques and education to improve their hemoglobin A1c.  This project served as an evidence-
based performance project framed by the Iowa model for evidence-based performance.  The 
project design was based on extensive evidence in the literature and congruent with the steps of 
the Iowa model.  Triggering issues surrounding the care of T2DM patients in underserved 
communities were identified and a team was developed to review the literature and address this 
issue.  The scholarly project team leader sought out to recruit 60 participants.  However, only 30 
participants were obtained during the three-month intervention window for daily utilization of 
the Diabetes app. Prior to receiving the app, patients received education on its usage.  The 
project team leader utilized phone contact for this education, plus provided an in-app welcome 
video tutorial.  Pre- and post-Diabetic app questionnaires (demographics, self-care) were 
distributed for baseline levels before and after the intervention.  Additionally, participants 
received push notifications daily at 8am and 6pm.  Prior to implementation of the Diabetes app, 
each participant had their hemoglobin A1c drawn pre- and post-app-utilization.  
Measurable Outcomes  
Goal 1: After completion of the three-month window with utilization of the Diabetes app, 
patients would demonstrate a decrease in their Hgb A1c.  This measurement would be evidenced 
by comparing blood drawn pre- and post-Diabetic app utilization.  Goal 2: After completion of 
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the three-month intervention of the Diabetes app, patients would demonstrate an increase in self-
care management behaviors associated with their T2DM.  This measurement would be evidenced 
by increased self-care management scores ranked by the Likert scores for all questions on the 
pre- and post-survey Diabetic Self-Questionnaire (Appendix C). 
Setting 
This scholarly project was conducted in a small rural town in Virgina.  Census results 
revealed approximately 1600 people living in the selected study area (Bassett, Virginia [BV], 
n.d.).  Approximately 72.94% of these people were White, 24.14% African American, 0.07% 
Asian American, and 1.79% other races (BV, n.d.).  The average median income in Bassett was 
$28,359.  Of the households 22.6% have children under the age of 18.  About 17.8% of the 
population lived below the poverty line (BV, n.d.).   
The health clinic is a community health center located in rural Virginia.  It is a 10-room 
medical facility, with over 20 employees ranging from certified medical assistants, licensed 
practical nurses, translators, clinical supervisor, clinical director, registered nurses, five nurse 
practitioners, two physicians, and is equipped with an in-house lab including EKG capabilities, 
microscope, and performs various in clinic procedures.  This family practice is dedicated to 
providing comprehensive, primary health services to medically underserved residents of Henry 
County regardless of their ability to pay.  This health center receives grant funding program 
under the 24 U.S.C 254b and is deemed a public health service employer (Rural Health Clinic, 
2018).  The clinical director of the organization provided a letter of support for the study taking 
place at the site (see Appendix D). 
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Population and Sample 
Participants of this study consisted of those who met inclusive criteria.  The scholarly 
project team leader selected approximately 60 particpants within the inclusive criteria.  The 
targeted audience for this scholarly project was adults aged 19-70 years of age with a diagnosis 
of T2DM for more than six months.  Patients were required to have access to iOS or Android 
device app stores with online capabilities.  Patients were required to be established patients of the 
clinic with a hemoglobin A1c greater than seven.  In addition, participants were required to have 
been referred to the diabetic educator within the last 12 months and English speaking only.  
Exclusion criteria consisted of falling outside the designated age range, not having mobile device 
access, not having smartphone capablities (app store), not being a rural clinic patient, not 
speaking English, and having an hemoglobin A1c lower than seven or without a diabetic 
educator referral within the last 12 months.    
Ethical Considerations  
The scholarly project team leader and project chair completed extensive research ethics 
training to ensure protection of human subjects through the Collaborative Institutional Training 
Initiative (CITI Training) and were awarded a certificate of successful completion (see Appendix 
E).  All aspects of the scholarly project were reviewed to ensure ethical standards were 
maintained throughout the implementation of the scholarly project.  The team leader reviewed all 
aspects within the study to ensure the highest level of quality and integrity throughout the 
duration of the project.  The scholarly project was approved by the project chair and received 
successful Liberty University Institutional Review Board (IRB) approval (see Appendix F).  All 
study participants were under a direct voluntarily basis, and at any time reserved the right to un-
enroll from the project. 
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The scholarly project team leader distributed and retrieved in person the informed 
consent forms during patients’ acute and chronic care visits.  Each participant’s reading level 
was assessed to ensure adequate reading literacy associated with participating in this scholarly 
project.  Scholarly project participants’ personal information remained confidential and 
anonymous throughout utilization of the Diabetes app intervention period.  All participants 
received an informed consent and non-disclosure statement for participating in the scholarly 
project (see Appendix G).  According to the disclosure forms provided to patients at the time of 
signing the informed consent, information was only discussed with direct scholarly project team 
members.  No personal information was shared with any other institutions or similar programs 
without direct consent from participants.  All patient information was carefully stored in an 
Excel spreadsheet on an encrypted laptop.  The scholarly project team leader reviewed all 
aspects of the scholarly project to ensure the safety of all study participants prior to 
implementation of the scholarly project.  The scholarly project was not associated with any paid 
firms and or institutions and did not receive any compensation for completion of this project.  
Each study participant was assigned a coded number that was associated to them with generated 
data for confidentiality purposes.     
Data Collection  
Data collection consisted of various tools utilized within this scholarly project. 
Participants had their hemoglobin A1c drawn pre- and post-intervention during this scholarly 
project.  Other data collection tools associated with this scholarly project consisted of: Diabetes 
app utilization (super user), diabetes self-care questionnaire with Likert ranking scoring 
(Appendix C), and a demographics questionnaire (Appendix H).  Study participants’ activity was 
tracked via google analytics for detailed app utilization (number of logins, individualized screen 
MOBILE-BASED APP FOR TYPE 2 DIABETES MANAGEMENT 35 
time, app functions, and personalized data tracker).  Each diabetic self-care questionnaire was 
distributed in addition to instructions within the Diabetes app.  Demographic questionnaires 
required participants to provide age, race, annual household income, current diabetic 
medications, and years living with diabetes.  The project team leader collected all completed 
questionnaires.  Lab collection took place in a secured sterile environment, and samples were 
collected by Labcorp employees within the inhouse lab during normal chronic care appointments 
for enrolled participants.  The project team leader collected all data utilizing the rural clinic E-
clinical electronic health record system for each participant. 
Tools 
The implementation of this scholarly project consisted of several tools designed to 
improve the self-care management of T2DM in the underserved patient population.  Participants 
were provided a 5-point Likert scale diabetes questionnaire and access for utilization of the 
Diabetes app.  The 5-point Likert scale diabetes self-care questionnaire was distributed pre- and 
post-implementation of the scholarly project.  Surveys evaluated each participant’s progression 
and initial self-care management levels.  The diabetes self-care questionnaire was a 10-question 
survey designed to evaluate self-care management techniques of patients with T2DM.  
Participants completed the questionnaire while in the office during their pre- and post-blood 
work obtained during the project time period.  
The Likert scale is a proficient scale of variability used in self-reported attitudes and 
behaviors (Hartley & Maclean, 2006).  Hartley & Maclean (2006) endorsed the Likert scale as 
consistently providing better response rates than traditional yes and no, either/or, and open-ended 
questions (Hartley & Maclean, 2006).  Each question was scored 1 through 5 consisting of: 1 
strongly disagree; 2 disagree; 3 neutral; 4 agree; and 5 strongly agree.  Overall scores were 
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totaled and placed into various categories based on raw scores.  Raw scores of participants were 
placed into the following categories utilizing a score bank sheet.  Scoring of the questionnaire 
was ranked per the following: 46-50 great; 41-45 good; 30-40 average; 20-29 poor; and 0-19 or 
below bad.  Appendix I presents the scale score ranking form.  Scores were based on the amount 
of self-care management techniques each study participant had at the time of completion before 
and after Diabetes app usage.  Literature supported patients with higher levels of self-care 
management techniques have better chronic care disease management.  This idea served as a 
driving force behind this scholarly project to improve various self-care management techniques.  
The following 10 items were utilized via the diabetic questionnaire utilizing the previous 
corresponding Likert point scale to answer each question.  (a) I check my blood sugar level at 
home at least once a day.  (b) I record my blood sugar level at least once per day.  (c) I take my 
diabetes medication at home as prescribed by my doctor or nurse practitioner.  (d) I follow the 
diabetic dietary recommendations given to me by my diabetic educator, physician, or nurse 
practitioner.  (e) I choose foods to eat that makes it easy to achieve good blood sugars levels.  (f) 
I plan my meals.  (g) I use healthy diabetic recipes to prepare my meals.  (h) I exercise 15 to 30 
min minutes at least 3 times a week.  (i) I keep all of the appointments recommended for my 
diabetes treatment.  (j) I use a diabetic app to help educate me on diabetes and health issues 
associated with diabetes (see Appendix C).  Hartley & Maclean (2014) reported utilization of the 
Likert scale consistently produced moderate to strong internal consistency, test-retest reliability, 
and concurrent validity.  This questionnaire tool was developed for the scholarly project and 
clinical setting and was not validated.   
The Diabetes app was the second tool utilized for this scholarly project.  The mobile-
based app consisted of several self-care management functions for enrolled users.  Users had 
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access to seven main app widgets located on the Diabetes app home screen, plus an additional 
information widget.  App widget one consisted of a welcome video that provided patients an 
overview of the scholarly project, project team leader introduction, goals during the three-month 
intervention period, and a detailed screen by screen display of mobile app features and functions 
shown directly by the project team leader (see Figure 1). 
 
Figure 1. Welcome video and diabetes home screen. 
 
App widget two consisted of pocket tools (daily blood sugar log, carb counter, and step 
counter) within the mobile app.  This widget provided patients the ability to track their blood 
sugar daily and have easier access to stored information for future acute or chronic care visits for 
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healthcare providers.  This widget also allowed patients to review blood sugar trends, manage 
carbohydrate intake for convenience food tracking, and step counter to monitor daily activity 
levels (see Figure 2).   
 
Figure 2. Pocket tools. 
 
App widget three consisted of a structured to do list.  Users were asked to complete as 
many tasks on the daily to do list as possible during the three-month intervention window.  The 
following tasks were assigned every day during the three-month intervention window.  Did you 
check your blood sugar today?  Did you take your diabetes medication today?  Did I eat things 
that help me achieve my blood sugar goals today?  Did I have the opportunity to exercise today, 
did I check my messages on the Diabetes app today, and did you give yourself credit for the 
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small things today? (making better choices when eating, exercising, taking your medication etc.) 
(see Figure 3).   
 
Figure 3. To do list. 
 
App widget four consisted of various educational YouTube videos (testimonials, diabetic 
education, exercise videos, and various dietary meal plans and recipes).  Healthy meal options 
were directly in accordance with the American Diabetes Association (ADA).  Dietary options 
consisted of developed meal options catered to lower socioeconomic patient population.  These 
items were from stores such as Walmart, ALDI, and Family Dollar.  Original meal plans covered 
breakfast, lunch, and dinner.  At the launch of the app, 21 meals were uploaded via various video 
resources.  New additional recipes and snacks were added each week consisting of snacks, 
breakfast, lunch, and dinner options.  All meal plans created and added by the project team 
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leader were developed in collaboration with the diabetic educator and congruent with dietary 
practice guidelines associated with the ADA (see Figure 4).  
 
Figure 4. Videos. 
 
App widget five, Did You Know, served as the main information hub associated with the 
mobile app.  This widget included information from the ADA on improving self-care 
management techniques and frequent high-risk topics associated with T2DM.  These self-care 
management techniques consisted of basic T2DM information on frequently asked questions, 
general medication information, exercise requirements, carbohydrate basics, medication 
education, frequent problems with T2DM, a clearly defined carb counting formula for dietary 
labeling, what to do on a sick day, foot care, eye care, hypoglycemia, hyperglycemia, injections, 
checking blood glucose, heart disease facts, smoking impact, and weight loss (see Figure 5).    
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Figure 5. Did you know. 
 
App widget six consisted of a Contact Us function.  Users were provided the direct 
ability to contact the project team leader or project team chair with any concerns or questions via 
phone call, text, or email.  App widget seven consisted of a Find Info function.  This widget 
provided registered users a list of all included resources and documented references for content 
provided within the mobile app (see Figure 6).  The goal was to encourage participants to 
explore the variety of resources available to help aid in effective management of those with 
T2DM.  Mobile app utilization for the management of self-care management techniques is 
appropriate and provides benefits, as presented in the review of literature.  For easy mobile 
installation, each participant, at the time of consent, received mobile app instructions for the 
Diabetes app (see Appendix J). 
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Figure 6. Contact us & find info. 
 
Intervention 
Scholarly project development started with the identification of current barriers to 
effective self-care management for patients with T2DM in the underserved patient population.  
The scholarly project team leader developed a scholarly project team to help develop an 
intervention to overcome barriers associated with ineffective self-care management techniques in 
the underserved patient population.  Goals associated with the Diabetes app aimed to improve 
self-care management of patients with T2DM in the underserved patient population and decrease 
overall hemoglobin A1c.  A careful literature review was conducted to construct the top app 
functions commonly associated with T2DM.  Next, the scholarly project team leader worked 
closely with Appy Pie software developers to develop a customizable app geared toward 
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improving the self-care management of patients with T2DM based on most evidence-based 
practices.      
Approximately 60 participants (non-random) were screened who met inclusive criteria of 
the scholarly project.  Of those who met inclusive criteria, 30 were unavailable to participate in 
the scholarly project or did not express interest within the required timeframe.  Out of the 
remaining 30 participants, nine participants dropped out the study before completion of the 
study.  Their various reasons included failing to turn in necessary requested questionnaires to 
establish baseline data to obtain access to the mobile-based app, withdrawal after prescreening 
conversation, and lack of consistent cellular service at the time.  The remaining 21 participants 
successfully completed all pre- and post-questionnaires, demographic forms, and utilization of 
the Diabetes app during the required three-month intervention period.   
The team leader of this scholarly project obtained in person consent from participants.  
Nursing staff were educated about the study; however, nursing staff did not have much contact 
with participants unless they came in for acute visits between their regular chronic care diabetic 
visits.  The team leader also placed at the nurse’s station a Diabetes mobile app instructional 
handout for any participants who came in for acute visits and needed additional resources or 
presented with questions.  A pre- and post- 10-question questionnaire utilizing the Likert scale 
was administered to all 21 participants in the scholarly project.  The scholarly project was 
implemented over a three-month period.  Participants during the three-month intervention 
window received two push notifications each day to their cellphones (8 am and 6 pm) consisting 
of various messages pertaining to better self-care management techniques associated with 
T2DM.  These messages consisted of content like the following examples.  (a) Hey, let’s get up 
and get active today!  (b) Did you check your blood sugar today?  (c) Did you remember to take 
MOBILE-BASED APP FOR TYPE 2 DIABETES MANAGEMENT 44 
your diabetic medication today?  (d) Check out these newly added healthy recipes inside the 
diabetes app today to help with cravings and help keep blood sugars down.  (d) Come check out 
the diabetes app today for new content, and various health tips to aid in effective T2DM 
management.  (Did you know?…etc) (see Figure 7). 
 
 
Figure 7. Notifications. 
 
Following the scholarly project intervention period, participants returned to the clinic to 
have their hemoglobin A1c redrawn and received the same 10-question Likert scale diabetes 
questionnaire after Diabetes app utilization.  Dissemination was conducted after implementation 
and evaluation of the scholarly project results.  After an extensive meeting, the clinic leadership 
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team concluded there was a significant improvement in hemoglobin A1c and self-care 
management techniques in patients who utilized the Diabetes app.  Each participant received a 
thank you letter for project participation.  The scholarly project participant with the highest 
correlating combined Diabetes app utilization, earliest project enrollment, and overall lowest 
decreased hemoglobin A1c won the 19-inch LCD television.  The winner of the 19-inch 
television had an overall hemoglobin A1c decrease of 2.8%, enrolled in the project within 2 
days, and had an increase in overall self-care management techniques by 34%! 
Timeline 
The scholarly project team leader spent 12 months on the project.  This timeline included 
the planning, pre-implementation, implementation, and evaluation periods of this scholarly 
project.  Please refer to Appendix K for a detailed table of the timeline of this scholarly project.   
Feasibility Analysis 
Various steps were taken by the scholarly project team leader to ensure the most cost-
effective and efficient measures were utilized while implementing the scholarly project.  
Resources needed for this scholarly project included: various personnel within the clinic, various 
resources and technology, and a strategic financial analysis of all mobile-based app technology.  
Personnel at the clinic had a marginal role during this scholarly project.  Personnel consisted of 
ancillary staff and LPNs within the organization.  Staff were only used to direct study patients 
who may have come in for acute visits during the study period.  Project resources were readily 
available at the clinic for project participants during the project period and consisted of pre-made 
Diabetes app booklets.  The project team leader was available via email and phone for all study 
participants with an anticipated 24-hours’ window response rates.  Most staff participation 
associated with this scholarly project were utilized in a capacity that did not require 
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compensation from the project team leader.  Any other staff within the clinic were compensated 
accordingly in line with their hourly rates associated with their employment within the 
organization.   
Resources needed to draw pre- and post- hemoglobin A1c levels consisted of utilizing the 
Labcorp within the selected facility, E-clinical health work network system to store all patient 
information, and various handouts (consent, instructional guide, pre and post-survey 
questionnaire, demographics questionnaire).  All personnel associated with Labcorp are 
contracted and paid by the clinic and obtained labs associated with participants during their 
regularly scheduled chronic care visits.  A 19-inch Vizio television was purchased for $45.00.  
The Diabetic app start-up costs required a one-time fee of $10.00, with a monthly access fee of 
$15.00 per month.  Feasibility of the scholarly project was extremely reasonable compared to 
incurred costs of patients who have persistent uncontrolled T2DM and associated hospital 
admissions and other associated health complications.  Overall resources and ancillary staff 
involvement associated with the utilization of the Diabetes app were previously assigned job 
functions within the rural clinic.  Financial analysis revealed total incurred costs associated with 
this scholarly project at $95.00.  This is a marginal price compared to the billions of dollars spent 
each year in our healthcare system.   
Data Analysis 
Data analysis consisted of utilizing SPSS software to analyze established measurable 
outcomes for the scholarly project.  SPSS software was utilized to identify correlations and 
relationships between Diabetes app utilization and the direct impact on self-care management 
techniques and hemoglobin A1c.  Correlations were generated in the form of participants’ overall 
hemoglobin average means, standard deviations, maximum, minimum, overall percentages, 
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paired t-test, p-values, and Pearson correlation values to help evaluate and establish the level of 
significance for the scholarly project.  User activity was recorded during the three-month 
intervention period and tracked utilizing google analytics.  Google analytics provided both real-
time data and overall time of users’ day to day mobile app usage.  Generated data consisted of 
providing response times to push notifications, widget usage, and the amount of screen time per 
user utilizing the app.  This information was generated and projected in reports via bar graphs, 
actual minutes, and percentages for each individual number of clicks per widget for each end 
user participating in the scholarly project.  The pre-and post-survey information was analyzed 
using SPSS software to determine differences in patient’s self-care management after the three-
month intervention.  Data was formulated and integrated to identify trends and success for the 
evidence-based practice scholarly project. 
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SECTION FOUR: RESULTS 
Out of 60 participants recruited 30 turned in all the required forms for participation in the 
scholarly project.  Of those, 21 participants successfully completed the demographics 
questionnaire (Appendix H) and self-care management questionnaire (Appendix C) pre- and 
post-Diabetes app utilization during the intervention period, and had required blood work drawn 
for hemoglobin A1c evaluation before and after Diabetes app utilization.  Nine participants 
dropped out of the scholarly project, because they failed to complete pre- and post-study 
bloodwork for hemoglobin A1c evaluation, voluntary withdrawal, or were unable to complete 
the self-care management questionnaires required for baseline data collection before or after the 
study period window.   
Utilization of mobile-based technology for this scholarly project demonstrated significant 
results in both improving the self-care management and decreasing hemoglobin A1c of study 
participants in a rural underserved patient population.  Demographics of the scholarly project 
group reflected a yearly mean income of 17,986 dollars.  N = 21 had a mean age of 43 years old, 
(min = 19, max = 70).  The mean age of participants since diabetic diagnosis was 11 years (min 
= 1, max = 30).  Participants in this scholarly project presented with the following education 
levels: some college 14.2%, high school or diploma equivalent 42.9%, and did not finish high 
school 42.9%.  See Table 1 for characteristics and Table 2 for education and ethnicities of 
participants. 
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Table 1  
Characteristics 
Items Means SD Min/Max N 
Age 45.19  15.33 19/70 21 
Years with Diabetes 11.28  6.73 1/30 21 
Yearly Income 18,399  8318.69 1000/37,000 21 
Number of Diabetic 
Medications 
1.95 1.02 0/4 21 
Notes: SD= Standard Deviation, N=number of participants  
 
 
Table 2  
Education and Ethnicity 
Education Frequency Percent N 
Some College 3 14.3 21 
High School or Diploma Equivalent 9 38.1 21 
Did not complete high school  9 47.6 21 
Graduate Degree 0 0 21 
Ethnicity    
Caucasian  9 42.9 21 
African American or Black 8 38.1 21 
Hispanic or Latino 4 19 21 
Other 0 0 21 
Sex    
Male 5 23.8 21 
Female  16 76.2 21 
Notes: All applicants had the option to leave any information undisclosed 
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Higher education of participants was associated with a lower incidence of uncontrolled 
chronic disease management historically in various models aimed to improve the hemoglobin 
A1c values.  Participants reflected lower hemoglobin A1c control congruent with lower 
educational levels associated with not completing high school versus high school diploma and 
completing some college (see Table 3).  In this project, N = 21 with gender represented as 28.2% 
male and 76.2% female.  Approximately 42.9% of participants did not complete high school, 
42.9% completed high school or high school equivalent, and 14.2% of participants completed 
some college.  Data revealed lower educational levels were associated with less effective chronic 
care disease management evidenced by less hemoglobin A1c management.  Poor hemoglobin 
A1c management is directly associated with increased health risk factors and increased mortality 
associated with prolonged uncontrolled management of T2DM.    
 
Table 3  
Educational Level Group and Average Hemoglobin A1c 
Items Mean A1c N 
Some College 7.9 21 
High School Diploma or 
Equivalent 
8.24 21 
Did Not Complete High 
School 
9.3 21 
 
Descriptive Statistics  
Overall utilization of the Diabetes app during the three-month intervention window 
demonstrated an improvement in overall hemoglobin A1c and self-care management techniques.  
Futhermore, evidence demonstrated a direct improvement in self-care management techniques 
based on average, good, and great overall ratings on initial self-care management techniques 
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increased to 14.3% from 12.6% (+1.7%) after Diabetes app utilization.  Participants who scored 
poor and bad  based on the Likert ranking score questionnaire had an initial mean of 30.9% 
down to 9.52% (-21.38% ) for self-care management techniques in the previously mentioned 
categories after Diabetes app utilization.  Users also demonstrated an overall mean decrease of 
2.34% hemoglobin A1c and overall decreased minimum and maximum hemoglobin A1c values 
of (min = -1, max = -3.3) with app utilization.  
Measurable Outcome 1.  
Goal 1: After completion of the three-month Diabetes app intervention, patients would 
demonstrate a decrease in their Hemoglobin A1c, evidenced by blood work drawn pre- and post- 
app utilization during the designated three-month intervention window.  Participants presented a 
significant hemoglobin A1c drop after utilization of the Diabetes app during the three-month 
intervention window with an overall hemoglobin A1c mean decrease from prior to utilization of 
the Diabetes app by 2.34% during the overall total three months’ evaluation (see Table 4).  
Table 4  
Pre- and Post-Diabetes App Utilization 
Items Mean 
A1c% 
SD P-value Min/Max N 
Pre-Diabetes App 
Hemoglobin A1c 
9.65 1.04 .004 7.20/11.90 21 
Post-Diabetes App 
Hemoglobin A1c 
7.31 .600 .004 6.20/8.60 21 
Notes: Mean A1c = Hemoglobin A1c, SD = Standard Deviation, Min/Max = Minimum 
Hemoglobin A1c, Max Hemoglobin A1c, N = Sample Participant size 
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Measurable Outcome 2.  
Goal 2: After completion of the three-month intervention of the diabetes app, patients 
would demonstrate an increase in self-care management behaviors associated with their T2DM.  
The accomplishment of this goal was demonstrated by an increase in the overall average Likert 
ranking scores based on the Diabetes self-care questionnaire compared to the pre- and post-
Diabetes app utilization (see Table 5) for Likert ranking scores.  
Table 5  
Pre- Intervention Likert Ranking Scores with Correlating Hemoglobin A1c 
Notes: N=Number of participants, Difference= Pre and Post Diabetes app utilization 
 
Items Mean 
Hemoglobin 
A1c 
Number of 
participants 
in category 
Percent of 
select 
categories 
P-Values Difference N 
46-50 Great 0 0 0 .015 0 21 
41-45 Good 7.12 2 9.5 .012 0 21 
30-40 
Average 
8.13 6 28.5 .016 0 21 
20-29 Poor 9.15 7 33.3 .017 0 21 
0-19 Bad 10.75 6 28.5 .018 0 21 
Post Diabetes App- Intervention Likert Ranking Scores with Correlating Hemoglobin 
A1c 
 
46-50 Great 6.25 2 9.52 .006 +9.52% 21 
41-45 Good 6.8 4 19.04 .004 +9.54% 21 
30-40 
Average 
7.58 11 52.38 .004 +23.88% 21 
20-29 Poor 8.45 3 14.28 .003 -19.02% 21 
0-19 Bad 8.60 1 4.76 .002 -23.74% 21 
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Utilization of the Diabetes app demonstrated a positive correlation between app usage 
utilization and improved self-care management.  Users in the poor and bad categories 
demonstrated a significant overall improvement.  All users had their activity tracked via google 
analytics.  Google analytics provided generated data associated with everyone’s app usage.  
Usage was provided on each user’s daily app screen time, response time to push notifications, 
most used app functions, and top widget selections.  Participants with the highest amount of 
screen time and Diabetes app interaction had a higher decrease in overall hemoglobin A1c during 
the three-month intervention window (see Table 6). 
Table 6  
Google Analytics and Corresponding Average Hemoglobin A1c 
Daily Usage Percent of Users Mean Hemoglobin 
A1c decrease 
N 
3.5 or more hours per 
week with at least 14 
widget functions per 
week 
(8)  38.09%  1.1 % 21 
2 to 3.4 hours per 
week with at least 10 
widget functions per 
week 
(6)  28.57% .92 % 21 
1 to 3.3 hours per 
week with at least 5 
widget functions per 
week 
(4) 19.04% .68 % 21 
0.5-3.1 hours per 
week with at least 2 
widget functions per 
week 
(3) 14.28% .54% 21 
Notes: N = Sample size of participants Items: All participants were rounded in the closest group 
when placing into categories for weekly measurements. 
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SECTION FIVE: DISCUSSION 
Implications for Practice   
We have a rapidly evolving healthcare system with progressively more complex disease 
processes than ever before.  Healthcare must find innovative methods to optimize patient 
outcomes with T2DM.  Thus far, healthcare is losing the battle to effective T2DM management 
at the exponential rate of billions of dollars each year.  In a technological era, utilization of the 
Diabetes app provided evidence that endorse further innovative ways to challenge barriers 
associated with ineffective self-care management of patients with T2DM in the underserved 
patient population.  This scholarly project demonstrated mobile-based technology needs to be 
incorporated into clinical practice guidelines associated with management of T2DM.   
Updated clinical guidelines incorporating the utilization of mobile-based technology will 
optimize the delivery of healthcare management for patients in the underserved patient 
population.  Mobile-based technology will serve to help patients achieve their target glycemic 
goals and reduce mortality and morbidity.  Additionally, incorporation of mobile-based 
technology into clinical practice guidelines will directly improve access to healthcare for those in 
underserved patient populations, offer creative ways to help engage patients to manage their 
T2DM, and expand the ability of diabetic educators and providers to reach patients and increase 
overall engagement.  
Highest functionality associated with the Diabetes app gave healthcare providers clear 
defined advantages over traditional diabetic educational methods and self-learning alone.  
Streamlining real-time blood sugars promotes the ability for healthcare providers to make faster 
recognition of patients’ glycemic control levels and aid in proper adjustments to help reduce 
prolonged hypo or hyperglycemic events leading to uncontrolled hemoglobin A1c levels 
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between three, six, and even 12-month intervals of chronic care visits.  Videos within the 
Diabetes app provided users additional educational resources for later recall outside of traditional 
15 to 20-minute chronic care visits and 30 to 60-minute diabetic education class sessions.  Video 
media within the Diabetes app also provided users an innovate advantage for positive 
reinforcement and quick access to recall critical self-care management techniques by personal 
testimonials, exercise videos, and dietary meals to help facilitate better lifestyle choices.   
Another great function of the Diabetes app was the use of self-care management icons 
with a variety of information about T2DM and daily to-do list.  Diabetes is one of the largest 
healthcare disparities within the United States with rapidly increasing costs, changes with 
medication administration, and continual rapid evolvement of oral glycemic agents and insulin 
medications advancements each year.  The heartbeat of effective T2DM is self-care management 
techniques.  If creative ways to improve self-care management techniques are not incorporated 
into clinical guidelines, ineffective management of T2DM will always serve as a tremendous 
challenge and burden within the healthcare system.  This scholarly project had no conflict of 
interest identified during the administration.  Additionally, no biases were associated with the 
implementation of this study.   
Limitations 
This scholarly project was conducted for the sole purpose of improving the self-care 
management and decreasing the hemoglobin A1c of those with T2DM in the underserved patient 
population.  Project limitations associated with this scholarly project included a limited 
timeframe to implement this study for the scholarly project team leader.  Time limitations 
directly influenced the available number of participants recruited for the scholarly project.  
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Furthermore, the inability to attract Hispanic patients served as a limitation due to a language 
barrier, and those with limited phone access or non-smartphone app capabilities.   
Sustainability  
Sustainability is one of the most challenging considerations when developing changes in 
how future healthcare is delivered.  The project site, as a rural low-income clinic, is designated 
as a Federally Qualified Healthcare Center (FQHC).  The clinic can challenge the longevity of 
imposed practice guidelines with limitations on resources such as finances, staffing, and 
challenging patient populations.  Adherence of healthcare providers to newly introduced mobile-
based technology is another important aspect to consider when implementing changes in clinical 
practice guidelines.  The rural health clinic must consider how to keep patients engaged with 
newly introduced mobile-based technology.  Resources should be considered and immediate, 
short term, and long-term goals established.  Additionally, the clinic must consider the 
incorporation of the Diabetes app into current existing clinical practice guidelines for T2DM 
management, the finances required to sustain mobile-based technology efforts, and the driving 
force needed to continue developing the Diabetes app congruent with T2DM overall national 
guideline changes.  Long-term goals must include materials; staff for developing, implementing, 
and continuing new guideline procedures; materials for participants; and staff and healthcare 
provider education. 
Healthcare staff adoption is another critical aspect in the success of this newly suggested 
clinical guideline.  Professional adherence is known to decrease as much as by 50% in relation to 
personal bias, lack of understanding, and perceived quality of the guideline (Amet et al., 2015). 
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Therefore, strong efforts must be taken to ensure all healthcare providers are provided adequate 
education to effectively utilize the Diabetes app as a new clinical guideline for T2DM 
management. Maintaining the immediate, short-term, and long-term goals rather than focusing 
on short-term actions and short-term effect have been demonstrated from various research to 
improve clinical guideline changes as much as 35% (Amet et al., 2015). 
How can mobile-based technology like the Diabetes app become a daily part of 
participants’ lives each day with T2DM?  The most popular mobile-based technology around 
offers user convenience and efficiency, provides a large spectrum of capabilities with reliability, 
and is generally user friendly.  Dependability is important for the Diabetes app in order to meet 
several of the previously mentioned user preferences to sustain participant engagement with a 
mobile-based app to aid with their chronic disease management.   
Utilizing the diabetic educator and healthcare providers’ input from users is very 
sustainable within the organization.  The rural health clinic diabetic educator is a full-time staff 
member with a great vantage point to identify needs and barriers that struggling patients with 
T2DM face each day.  Two forms of feedback will be generated through diabetic education 
sessions and traditional chronic care visits conducted by healthcare providers.  Longevity of this 
scholarly project solely lies on the efforts and collaboration between the diabetic educator and 
healthcare providers.  Upkeep of the mobile-based technology is easy with advanced Software 
developers like Appy Pie.  The complexity and variations associated with the development of 
mobile apps is simplified for input users to easily update and add new content.  The same effort 
required to upkeep and maintain standard guidelines for T2DM within the clinic can be applied 
to updating the Diabetes app.  However, these efforts serve to be a much more innovative way to 
reach more patients effectively than traditional methods.  Prioritizing methods with a constant 
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evolving healthcare system should make efforts easier towards implementing methods that 
encourage patients to become more a part of their chronic disease management.  
Dissemination Plan   
Evidence demonstrated by this scholarly project endorses the utilization of mobile-based 
technology (Diabetes app), which effectively helped manage T2DM patients in the underserved 
patient population.  The scholarly project achieved two measurable outcomes over the three-
month intervention window after Diabetes app utilization.  First, the Diabetes app demonstrated 
a decrease in overall end users’ hemoglobin A1c, directly related to daily app usage.  Second, the 
Diabetes app directly improved the self-care management of T2DM in the underserved patient 
population.  Evidence supported a positive correlation with increased app usage and higher self-
care management scores after baseline and during the intervention window.   
The scholarly project was developed for multiple applications in a variety of clinical and 
non-clinical settings.  The primary targeted audience for this scholarly project were those in the 
underserved patient population.  Beyond the target audience group the development behind the 
Diabetes app served a much bigger purpose to help fight the seventh leading cause of death in 
the United States.  The Diabetes app was developed to be an innovative tool that could be used 
by underserved patients, healthcare providers, healthcare centers, educators, and family and 
friends. Partners associated with the Diabetes app consisted of a variety of sources in the 
community. 
The project study site receives federally funding from Health Resource Service 
Administration (HRSA).  HRSA has gone through extra lengths to improve the overall standards 
of T2DM management across all FQHC receiving federally qualified funding as of 2018.  Most 
recent operational site visits require FQHC to establish a diabetic performance analysis goal over 
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a year, with quarterly progress reports aimed towards improving patients’ hemoglobin A1c levels 
greater than nine throughout all health centers.  The Diabetes app and utilization of mobile-based 
technology will be shared as a part of various clinic initiatives to help obtain better controlled 
hemoglobin A1c values.  Information will be utilized and placed on the universal FQHC website 
to serve as a resource for other FQHC to utilize within their organizations.  Furthermore, the 
scholarly project team leader started several initiatives to disseminate the results beyond 
traditional scholarly project publication.  The team leader has started progressive efforts towards 
developing a manuscript to meet submission requirements to the Diabetes Care scholarly 
publication. The project team leader has also taken efforts to produce the data and research on 
various chronic care disease blogs, social media (Facebook), and ADA’s In It Together blog. 
All submission research will be written to meet requirements of the submitting platform 
requirements to match the reader audience.  The Diabetes Care will follow requirements required 
for scholarly publications, specifically providing a breakdown of the scholarly project in a 
structured and formal methodical manner with associated medical terminology.  However, social 
media (Facebook) and ADA In It Together will be more informal presentations with the intent to 
provide a more personable approach to utilization of the Diabetes app for those with T2DM.  
Like the origin and development of this mobile app, the goal was to endorse a user-friendly 
platform app to encourage patients to manage their T2DM.  This scholarly project team leader 
had several opportunities to evaluate the effectiveness of this dissemination plan through various 
sources.  The HRSA website is an area for FQHC to provide posted feedback on similar 
protocols, policies, and new clinical guidelines.  Facebook and the ADA blog will provide real-
time responses from members to provide and engage users with new available resources.  The 
start of this dissemination plan relied on effective implementation within the clinic to 
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demonstrate the Diabetes app as an effective tool compared to traditional diabetic educational 
methods. 
Conclusion 
 We have a rapidly evolving healthcare system with progressively more complex disease 
processes than ever before.  Healthcare must find innovative methods to optimize patient 
outcomes with T2DM in the underserved patient population.  Thus far, healthcare is losing the 
battle to effective T2DM management at the exponential rate of billions of dollars each year.  In 
a technological era, utilization of the Diabetes app provided substantial evidence that endorsed 
further innovative ways to challenge barriers associated with ineffective self-care management of 
patients with T2DM in the underserved patient population. 
  
MOBILE-BASED APP FOR TYPE 2 DIABETES MANAGEMENT 61 
References 
Alexander, M., Christopher, B., Shatz, M., Schick, T., Neauman, T., Kribbs, A., . . . Stefan, B. 
(2016). A mobile application improves therapy-adherence rates in elderly patients 
undergoing rehabilitation: A crossover design study comparing documentation via iPad 
with paper-based control. Medicine, 95(36), 4446. doi:10.1097/MD.0000000000004446 
Amet, S., Groot, J., Maseen, J., Dicksen, C., Weijden, T., & Kleijen, J. (2015). Sustainability of 
professionals’ adherence to clinical practice guidelines in medical care: A systematic 
review. BMJ Journals, 2, 15-30. doi.org/10.1136/bmjopen-2015-008073 
Arnold, M., Solz, D., Quade, M., & Kirch, W. (2014). Mobile applications for diabetics: A 
systematic review and expert-based usability evaluation considering the special 
requirements of diabetes patients age 50 years or older. JMIR Publications, 16(4), 104. 
doi:10.2196/jmir.2968 
Bassett Family Practice. (2018). From Martinsville Henry County Coalition for Health and 
Wellness. Retrieved from https://healthycommunitymhc.org/locations/bassett-family-
practice/ 
Bassett, Virginia. (2015). In Wikipedia. Retrieved July 12, 2018, from 
https://en.wikipedia.org/wiki/Bassett,_Virginia  
Beverly, E., Worley, M., Court, A. B., Prokopakis, K., & Ivanov, N. (2016). Patient physician 
communication and diabetes self-care. Journal of Clinical Outcomes Management, 
23(11), 509-518. Retrieved from 
https://www.mdedge.com/jcomjournal/article/146123/diabetes/patient-physician-
communication-and-diabetes-self-care 
  
MOBILE-BASED APP FOR TYPE 2 DIABETES MANAGEMENT 62 
Boyle, L., Grainger, R., Hall, R., & Krebs, J. (2017). Use of and beliefs about mobile phone apps 
for diabetes self-management: Surveys of people in a hospital diabetes clinic and diabetes 
health professionals in New Zealand. JMIR mHealth uHealth, 5(6), 85. 
doi:10.2196/mhealth.7263 
Cafazzo, J., Cassleman, M., Hamming, N., Katzman, D., & Palmert, M. (2012). Design of an 
mHealth app for the self-management of adolescent type 1 diabetes: A pilot study. JMIR, 
14(3), 70. doi:10.8898/10-93284 
Chavez, S., Fedele, D., Guo, Y., Bernier, A., Smith, M., Warnick, J., & Modave, F. (2017). 
Mobile apps for the management of diabetes. Diabetes Care, 40(10), 145-146. 
doi:10.2337/dc17-0853 
Cullen, L., & Adams, S. (2013). Planning for implementation of evidence-based practice. The 
Journal of Nursing Administration, 42(4), 222-230. 
doi:10.1097/NNA.0b013e31824ccd0a 
Desveaux, L., Shaw, J., Saragosa, M., Soobiah, C., Marani, H., Hensel, J., . . . Jeffs, L. (2018). A 
mobile app to improve self-management of individuals with type 2 diabetes: Qualitative 
realist evaluation. Journal of Medical Internet Research, 20(3), 81. 
doi:10.2196/jmir.8712 
Doody, C., & Doody, O. (2012). Introducing evidence into nursing practice: Using the IOWA 
model. Retrieved from 
https://pdfs.semanticscholar.org/d2c1/2d0a105e79a58ce1a939d89a8ac1df994717.pdf 
Duke, S., Colaguri, S., & Colaguri, R. (2015). Individual patient education for people with type 2 
diabetes mellitus. Cochrane Database System Review, 30-40. 
doi.org/10.1002/14651858.CD005268.pub2 
MOBILE-BASED APP FOR TYPE 2 DIABETES MANAGEMENT 63 
 
Garg, S., Shah, V., Aturk, H., Benson, C., & Benergeon, J. (2017). Role of mobile technology to 
improve diabetes care in adults with type 1 diabetes: The remote-tid study iBGStar in 
type 1 diabetes management. Diabetes Therapy, 8(4), 811-819. doi:10.1007/s13300-017-
0272-5 
Goh, G., Tan, N., Chaun, M., & Uma, B. (2015). Short-term trajectories of use of a caloric-
monitoring mobile phone app among patients with type 2 diabetes mellitus in a primary 
care setting care setting. JMIR Publications, 17(2), 33. doi:10.2196/jmir.3938 
Goyal, S., Morita, P., Lewis, G., Yu, C., Seto, E., & Cafazzo, J. (2016). The systematic design of 
a behavioral mobile health application for the self-management of type 2 diabetes. 
Canadian Journal of Diabetes, 40(1), 95-104. doi:10.1016/j.jcjd.2015.06.007 
Hartley, S. L., & Maclean, W. E., Jr. (2006). A review of the reliability and validity of Likert-
type scales for people with intellectual disability. Journal of Intellectual Disability 
Research, 50(11), 813-827. doi:10.1111/j.1365-2788.2006.00844.x 
Holmen, H. (2017). Mobile health for diabetes self-management (Unpublished doctoral 
dissertation). University of Oslo, Norway. Retrieved from 
https://www.duo.uio.no/bitstream/handle/10852/59412/PhD-Holmen-
DUO.pdf?sequence=1 
Hooker, R. S. (2013). Working with the medically underserved. Canadian Family Physician, 
59(4), 339-340. Retrieved from 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625069/ 
MOBILE-BASED APP FOR TYPE 2 DIABETES MANAGEMENT 64 
Hsu, C., Lee, C. H., Wahlqvist, M. L., Huang, H. L., Chang, H.Y., Chen, L., . . . Cheng, J. S. 
(2012). Poverty increases type 2 diabetes incidence and inequality of care despite 
universal health coverage. Diabetes Care, 35(11), 2286-2292. doi:/10.2337/dc11-2052 
Irvine, B., Russell, H., Manocchia, M., Mino, D., Glassen, T. C., Morgan, R., . . . Ary, D. V. 
(2015). Mobile-web app to self-manage low back pain: Randomized controlled trial. 
JMIR, 17(1), 1-10. doi:10.2196/jmir.3130 
Jo, I., Yoo, S., Lee, D., Park, C., & Kim, E. (2017). Diabetes management via a mobile 
application: A case report. Clinical Nutrition Research, 6(1), 61-67. 
doi:10.7762/cnr.2017.6.1.61 
Lithgow, K., Edwards, A., & Rabi, D. (2017). Smartphone app use for diabetes management: 
Evaluating patient perspectives. JMIR Diabetes, 2(1), 2. doi:10.2196/diabetes.6643 
Mallow, J. A., Theeke, L. A., Barnes, E. R., Whetsel, T., & Mallow, B. K. (2014). Using 
mHealth tools to improve rural diabetes care guided by the chronic care model. Online 
Journal Rural Health Care Nursing, 14(1), 43-65. doi:10.14574/ojrnhc.v14i1.27 
Mobile fact sheet. (2019). Retrieved from https://www.pewinternet.org/fact-sheet/mobile/ 
Nuti, L., Lawley, M., Turkcan, A., Tian, Z., Zhang, L., Chang, K., ... Sards, L. (2013). No-shows 
to primary care appointments: Subsequent acute care utilization among diabetic patients. 
BMC Health Services Research, 12(1), 304. doi:10.1186/1472-6963-12-304 
Patel, N., Datye, K., & Jesser, S. (2018). Importance of patient provider communication to 
adherence in adolescents with type 1 diabetes. Healthcare, 6(2), 30. 
doi:10.3390/healthcare6020030 
Perez, L., Alvarez, M., Dilla, T., & Guillen, V. (2013). Adherence to therapies in patients with 
type 2 diabetes. Diabetes Therapy, 4(2), 175-194. doi:10.1007/s13300-013-0034-y 
MOBILE-BASED APP FOR TYPE 2 DIABETES MANAGEMENT 65 
Research Guides. (2015). From the University of Michigan Library. Retrieved 
from https://guides.lib.umich.edu/c.php?g=282802&p=1888246 
Schreier, G., Eckman, H., Hayn, D., Kriener, K., Kastner, P., & Lovell, N. (2013). Web versus 
app – compliance of patients in a telehealth diabetes management programming two  
different technologies. Journal of Telemedicine & Telecare, 18(8), 476-480. 
doi:10.1258/jtt.2012.GTH112 
Schmocker, K. S., Zwahlen, F. S., & Denecke, K. (2018). Mobile app for simplifying life with 
diabetes: Technical description and usability study of GlucoMan. JMIR Publications, 
3(1), e6. doi:10.2196/diabetes.8160 
Shadid, A., Mahar, S. A., Shaikh, S., & Shaikh, Z. U. (2015). Mobile phone intervention to 
improve diabetes care in rural areas of Pakistan: A randomized controlled trial. Journal 
College Physician Pakistan, 25(3), 166-171. doi:03.2015/JCPSP.166171 
Shah, V. N., & Garg, S. K. (2015). Managing diabetes in the digital age. Clinical Diabetes and 
Endocrinology, 1(16), 20-36. doi:10.1186/s40842-015-0016-2 
Titler, M. G., Kleiber, C., Steelman, V. J., Rakel, B.A., Budreau, G., Everett, L. Q., ...Goode, C. 
J. (2001). The Iowa model of evidence-based practice to promote quality care. Critical 
Care Nursing Clinics of North America, 13(4), 497-509. Vencio, S., Paldánius, P. M., 
Blüher, M., Gianello-Neto, D., Caiado-Vencio, R., & Strain, W. D. (2017). 
Understanding the barriers and improving care in type 2 diabetes: Brazilian perspective in 
time to do more in diabetes. Diabetology and Metabolic Syndrome, 9(1), 46. 
doi:10.1186/s13098-017-0244-y 
MOBILE-BASED APP FOR TYPE 2 DIABETES MANAGEMENT 66 
Whitehead, L., & Seaton, P. (2016). The effectiveness of self-management mobile phone and 
tablet apps in long-term condition management: A systematic review. JMIR, 18(5), 97-
108. doi:10.2196/jmir.4883 
Ye, Q., Khan, U., & Boren, S. A. (2018). An analysis of diabetes mobile applications features 
compared to AADE7: Addressing self-management behaviors in people with diabetes. 
SAGE Journals, 12(4), 808-816. doi:10.1177/1932296818754907 
Yang, S., Kong, W., Hsue, C., Fish, A. F., Chen, Y., Guo, X., ... Anderson, R. (2016). 
Knowledge of A1c predicts diabetes self-management and A1c level among Chinese 
patients with type 2 diabetes. PLoS One, 11(3). doi:10.1371/journal.pone.0150753 
 
MOBILE-BASED APP FOR TYPE 2 DIABETES MANAGEMENT 67 
 
Appendices 
Appendix A 
Evidence Table  
Article Reference.  
Study 
Purpose 
Sample 
(Characterist
ics of the 
Sample: 
Demographic
s, etc.) 
Methods Study Results 
Level of 
Evidence 
(Use Melnyk 
Framework) 
Study 
Limitations 
Would Use as 
Evidence to 
Support a 
Change? (Yes 
or No) 
Provide 
Rationale. 
Alexander, M., 
Christopher, B., 
Shatz, M., Schick, 
T., Neauman, T., 
Kribbs, A., ... Stefan, 
B. (2016). A mobile 
application improves 
therapy-adherence 
rates in elderly 
patients undergoing 
rehabilitation: A 
crossover design 
study comparing 
documentation via 
iPad with paper-
based control. 
Medicine, 95(36), 
4446. 
doi:10.1097/MD.000
0000000004446 
This study 
focused on 
whether 
mobile 
application 
could support 
therapy 
management 
for patients 
with chronic 
conditions and 
improve 
therapy 
adherence 
(Alexander et 
al., 2016). 
N= 24 patient 
study. 
Non-
randomization 
trial.  
The mobile 
app for 
medication 
adherence 
increased 
objectively 
and 
subjectively 
medicine 
adherence 
(Alexander et 
al., 2016).  
Level III: 
Quasi 
Experimental 
Medication 
intake needed 
to be 
confirmed via 
iPad.  
Adherence 
was reported 
from patients 
does not 
confirm 
adhering to 
medication 
regimen, and 
short length of 
study 
(Alexander et 
al., 2016). 
Yes, this data 
is supportive 
of mobile 
technology 
increasing 
medication 
adherence. 
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Arnold, M., Solz, D., 
Quade, M., & Kirch, W. 
(2014). Mobile 
applications for diabetics: 
A systematic review and 
expert-based usability 
evaluation considering 
the special requirements 
of diabetes patients age 
50 years or older. JMIR 
Publications, 16(4), 104. 
doi:10.2196/jmir.2968 
 
 
Examined 
whether the 
available 
applications serve 
the special needs 
of diabetes 
patients aged 50 
or older by 
performing an 
expert-based  
usability 
evaluation 
(Arnold et al., 
2014). 
N=656 free apps 
N= 379 paid apps 
 
 
 
 
 
Performed app 
review based on 
the information 
given in the 
Google Play 
Store, the Apple 
App Store, and 
the apps 
themselves. In 
addition, we 
carried out an 
expert-based 
usability 
evaluation based 
on a 
representative 
10% sample of 
diabetes apps 
(Arnold et al., 
2014). 
With patient and 
physician input 
during the 
development of 
mobile apps for 
T2DM. Mobile 
apps can be a 
useful tool to 
assist in the 
management of 
T2DM. 
 
 
 
Level I: 
Systematic 
Review  
 
 
 
 
 
 
 
 
The systematic 
review was only 
on iOS and 
android 
platforms.  
Limiting the 
general number 
of available apps 
to research 
(Blackberry, 
google, Windows 
phone etc.) 
(Arnold et al., 
2014). 
 
 
Yes. Patients and 
physicians alike 
should be 
involved in the 
app development 
process to a 
greater extent. 
User performance 
of individuals 
aged 50 or higher 
was moderate to 
good (Arnold et 
al., 2014). 
 
Boyle, L., Grainger, R., 
Hall, R., & Krebs, J. 
(2017). Use of and beliefs 
about mobile phone apps 
for diabetes self-
management: Surveys of 
people in a hospital 
diabetes clinic and 
diabetes health 
professionals in New 
Zealand. JMIR mHealth 
uHealth, 5(6), 85. 
doi:10.2196/mhealth.726
3 
 
The purpose of 
this study was to 
see if the usage of 
apps in New 
Zealand for DM 
self-management 
and evaluate 
desirable features 
of apps. Also, to 
evaluate 
providers 
recommending 
app usage (Boyle, 
Grainger, Hall, & 
Krebs, 2017) 
12 months 
(N=539) assessed 
current app use 
and desirable 
features. A 
second survey of 
HPs attending a 
diabetes 
conference 
(n=286) assessed 
their confidence 
with app 
recommendations 
and perceived 
usefulness. 
This cross-
sectional study 
observational 
study 
The most favored 
app functions 
were recorded 
blood glucose. It 
recommends 
further 
developing 
assessment 
process to give 
confidence in the 
quality and safety 
of diabetes apps 
(Boyle et al., 
2017).  
Level V: 
Observational 
Study 
A large patient 
size was utilized, 
risk of over 
presentation by 
poor literate 
responders. Lack 
of access to keep 
up with app 
consistently.  
A large patient 
size was utilized, 
risk of over 
presentation by 
poor literate 
responders. Lack 
of access to keep 
up with app 
consistently. 
 
 
Cafazzo, J., Cassleman, M., 
Hamming, N., Katzman, 
D., & Palmert, M. (2012). 
Design of an mHealth app 
for the self-management 
of adolescent type 1 
diabetes: A pilot study. 
To design, 
develop, and pilot 
an mHealth 
intervention for 
the management 
of type 
1 diabetes in 
adolescents 
A pilot group of 
20 adolescents 
aged 12-16 years, 
with a glycated 
hemoglobin 
(HbA(1c)) of 
between 8% and 
Non-randomized 
control trial 
This mHealth 
diabetes app with 
the use of 
gamification 
incentives 
showed an 
improvement in 
the frequency of 
Level III: Quasi 
Experimental 
Limitations of 
this study are 
based on each 
user’s ability to 
effectively 
navigate the 
mobile app.  
Limited access to 
Yes, this study 
demonstrates that 
that the utilization 
of a mobile app 
improves the 
overall health 
outcome of 
patients with DM.  
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JMIR, 14(3), 70. 
doi:10.8898/10-93284 
(Cafazzo, 
Cassleman, 
Hamming, 
Katzman, & 
Palmert, 2012). 
10% was 
sampled. 
blood glucose 
monitoring in 
adolescents with 
type 1 diabetes 
(Cafazzo et al., 
2012). 
smartphone, and 
small group 
sample (Cafazzo 
et al., 2012). 
Chavez, S., Fedele, D., Guo, 
Y., Bernier, A., Smith, 
M., Warnick, J., & 
Modave, F. (2017). 
Mobile apps for the 
management of diabetes. 
Diabetes Care, 40(10), 
145-146. 
doi:10.2337/dc17-0853 
 
The purpose of 
this study was to 
assess whether 
popular apps for 
diabetes 
management 
enough quality to 
complement 
clinical care 
(Chavez et al., 
2017).  
A total of 120 
apps. Before 
download, we 
eliminated 
duplicate apps (n 
= 11), apps in 
Spanish (n = 3), 
prank apps (n = 
2), and a pet 
diabetes app (n = 
1). 89 remained 
after for usage 
(Chavez et al., 
2017).  
A meta-analysis 
(systematic 
review) 
This study 
suggested that 
additional work is 
needed to assess 
the clinical 
significance of 
apps for diabetes 
self-management, 
and that app 
developers should 
work closely with 
health care 
providers and 
patients when 
building such m 
Health tools 
(Chavez et al., 
2017). 
Level I: 
Systematic 
Review  
This study only 
included free 
apps. In addition, 
the study did not 
account for 
behavior or 
health outcomes 
Yes, this study 
provided a view 
at a great 
standardized tool 
to support the 
utilization of 
mobile app 
technology 
incorporated with 
diabetes 
management.  
Desveaux, L., Shaw, J., 
Saragosa, M., Soobiah, 
C., Marani, H., Hensel, J., 
. . . Jeffs, L. (2018). A 
mobile app to improve 
self-management of 
individuals with type 2 
diabetes: Qualitative 
realist evaluation. Journal 
of Medical Internet 
Research, 20(3), 81. 
doi:10.2196/jmir.8712 
 
The purpose of 
this study was 
aimed to evaluate 
a web-based 
solution for 
improving self-
management of 
diabetes type two 
(Desveaux et al., 
2018). 
N=26 interviews 
(14 baseline and 
12 follow-up) 
16 participants 
had T2DM 
Randomized wait 
control group 
Self-efficacy, 
competing 
priorities, 
previous 
behavior, and 
beliefs about web 
solutions 
influence 
utilization of web 
activity. Web 
solutions could 
tailor to improve 
diabetes 
management with 
suboptimal 
management  
(Desveaux et al., 
2018).  
Level II: 
Experimental 
Design 
Participation in 
this study was 
voluntary, which 
could result in 
selection bias. 
Limited ability of 
transferring data 
applicable to 
larger population 
with small study 
size (Desveaux et 
al., 2018). 
Yes, this study 
utilizes enough 
data to support 
the potential for 
mobile app 
influence on DM 
management. 
Sample size 
significant 
enough to provide 
insight for future 
study.  
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Garg, S., Shah, V., Aturk, 
H., Benson, C., & 
Benergeon, J. (2017). 
Role of mobile 
technology to improve 
diabetes care in adults 
with type 1 diabetes: The 
remote-tid study iBGStar 
in type 1 diabetes 
management. Diabetes 
Therapy, 8(4), 811-819. 
doi:10.1007/s13300-017-
0272-5 
To further 
evaluate the 
effectiveness of 
mobile 
technology in 
relation to patient 
related outcomes 
(Garg, Shah, 
Aturk, Benson, & 
Benergeon, 2017) 
N=100  
N=50 iBGstar 
app 
N= control group 
 
Randomized trial  The mobile app 
ibgstar app had 
the same amount 
of hemoglobin 
A1c decrease at 
three months. 
However, at 6 
months the 
iBGstar had an 
increased 
decrease in 
hemoglobin A1c 
(Garg et al., 
2017). 
 
Level II: 
Experimental 
design 
Short term only 
limited to six 
months. Only 
conducted within 
one facility and 
could not be used 
for generalization 
of results (Garg et 
al., 2017). 
Yes, this data was 
strongly 
supported. 
Goh, G., Tan, N., Chaun, 
M., & Uma, B. (2015). 
Short-term trajectories of 
use of a caloric-
monitoring mobile phone 
app among patients with 
type 2 diabetes mellitus in 
a primary care setting. 
JMIR Publications, 17(2), 
33. doi:10.2196/jmir.3938 
 
 
 
The objective of 
this study is to 
identify and 
describe short-
term (8-week) 
trajectories of use 
of the iDAT app 
among patients 
with type 2 
diabetes mellitus 
in a primary care 
setting in 
Singapore and 
identify patient 
characteristics 
associated with 
each trajectory 
(Goh, Tan, 
Chaun, & Uma, 
2015). 
A total of 84 
patients with type 
2 diabetes 
mellitus from a 
public primary 
care clinic in 
Singapore who 
had not 
previously used 
the iDAT app 
were enrolled 
Non-randomized 
control study 
This study 
provides insight 
into the nature 
and extent of 
usage of a 
caloric-
monitoring app 
among patients 
with type 2 
diabetes and 
managed in 
primary care. 
This study 
provided a vital 
framework for 
future mobile app 
management of 
DM (Goh et al., 
2015).  
 
Level III: Quasi 
Experimental  
Smaller sample, 
with limited 
length of study 
time. 
Results limited to 
one facility, 
reduces 
generalization to 
the general 
population.  
Yes, this study 
provides sound 
support for the 
utilization of 
mobile app 
technology in the 
management of 
patients 
diagnosed with 
DM. It offers a 
great tool to help 
patients with self-
care management.  
 
Goyal, S., Morita, P., Lewis, 
G., Yu, C., Seto, E., & 
Cafazzo, J. (2016). The 
systematic design of a 
behavioral mobile health 
application for the self-
management of type 2 
diabetes. Canadian 
Journal of Diabetes, 
The present 
study asked if 
the addition of a 
tailored mobile 
coaching (TMC) 
system to current 
primary care for 
diabetes 
management 
resulted in better 
Maintenance (I-
M) group 
(n = 74) and 
Control-
Intervention (C-
I) group 
(n = 74).  
Randomized, 
controlled, open-
label trial, 
conducted from 
October 2014 to 
December 2015 
in Kangbuk 
Samsung 
Hospital, Seoul, 
Korea, and 
In this study, we 
evaluated the 
effect of TMC in 
diabetes care 
when added to 
the usual current 
diabetes 
management and 
investigated 
whether this 
Level II: 
Experimental 
design 
Medication 
compliance could 
not be confirmed. 
User 
comprehension of 
the TMC system 
was not 
considered.  
Yes, strong data 
was presented in 
this well-
controlled study 
for better 
glycemic control 
via mobile 
technology.  
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40(1), 95-104. 
doi:10.1016/j.jcjd.2015.0
6.007 
 
glycemic control 
and other 
diabetes-related 
outcomes in 
adult patients 
with type 2 
diabetes 
compared to 
standard diabetes 
management 
(Goyal et al., 
2016). 
consisted of 2 
phases 
effect was 
repeatable in 
other participants 
and maintained 
without active 
intervention. 
After 6 months, 
HbA1c levels 
were 
significantly 
decreased by 
0.6%. This 
improvement 
was reproduced 
in the other 
group of 
participants and 
remained after 
removal of 
individualized 
message 
feedback (Goyal 
et al., 2016). 
Holmen, H. (2017). Mobile 
health for diabetes self-
management 
(Unpublished doctoral 
dissertation). University 
of Oslo, Norway. 
Retrieved from 
https://www.duo.uio.no/b
itstream/handle/10852/59
412/PhD-Holmen-
DUO.pdf?sequence=1 
 
The present 
study asked if 
the addition of a 
tailored mobile 
coaching (TMC) 
system to current 
primary care for 
diabetes 
management 
resulted in better 
glycemic control 
and other 
diabetes-related 
outcomes in 
adult patients 
with type 2 
diabetes 
compared to 
standard diabetes 
management 
(Holmen, 2017). 
Maintenance (I-
M) group 
(n = 74) and 
Control-
Intervention (C-
I) group 
(n = 74).  
Randomized, 
controlled, open-
label trial, 
conducted from 
October 2014 to 
December 2015 
in Kangbuk 
Samsung 
Hospital, Seoul, 
Korea, and 
consisted of 2 
phases (Holmen, 
2017). 
In this study, we 
evaluated the 
effect of TMC in 
diabetes care 
when added to 
the usual current 
diabetes 
management and 
investigated 
whether this 
effect was 
repeatable in 
other participants 
and maintained 
without active 
intervention. 
After 6 months, 
HbA1c levels 
were 
significantly 
decreased by 
0.6%. This 
Level II: 
Experimental 
Design 
Medication 
compliance could 
not be confirmed. 
User 
comprehension of 
the TMC system 
was not 
considered.  
Yes, strong data 
was presented in 
this well-
controlled study 
for better 
glycemic control 
via mobile 
technology.  
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improvement 
was reproduced 
in the other 
group of 
participants and 
remained after 
removal of 
individualized 
message 
feedback 
(Holmen, 2017). 
Irvine, B., Russell, H., 
Manocchia, M., Mino, D., 
Glassen, T. C., Morgan, 
R., . . . Ary, D. V. (2015). 
Mobile-web app to self-
manage low back pain: 
Randomized controlled 
trial. JMIR, 17(1), 1-10. 
doi:10.2196/jmir.3130 
 
This study 
evaluated the 
efficacy of 
a mobile-Web 
intervention 
called "FitBack" 
to help users 
implement self-
tailored strategies 
to manage and 
prevent NLBP 
occurrence 
(Irvine et al., 
2015). 
597 adults were 
recruited, 
screened, 
consented, and 
assessed online at 
baseline, at 2 
months (T2), and 
at 4 months (T3). 
NRCT This research 
demonstrated that 
a theoretically 
based stand-
alone mobile-
Web intervention 
that tailors 
content to users 
preferences and 
interests can be 
an effective tool 
in self-
management 
of low back pain 
(Irvine et al., 
2015) 
Level III: 
Quasi 
Experimental 
User knowledge 
of technology 
(web application 
and app).  
Yes, data 
supported from 
this study 
indicates several 
indications for 
various chronic 
illness.  
Jo, I., Yoo, S., Lee, D., 
Park, C., & Kim, E. 
(2017). Diabetes 
management via a mobile 
application: A case 
report. Clinical Nutrition 
Research, 6(1), 61-67. 
doi:10.7762/cnr.2017.6.1.
61 
 
The Healthy-note 
app was designed 
to enable patients 
to record and 
monitor self-
management 
activities 
(SMBG, diet, 
exercise, and 
medication), 
providing the 
patient with a 
self-learning 
function (Jo, 
Yoo, Lee, Park, 
& Kim, 2017). 
Two case study 
patients utilizing 
healthy note app.  
Cohort Study Mixed results. 
Patient one who 
was actively 
engaged in 
mobile app had a 
decrease in 
Hemoglobin A1c 
(Jo et al., 2017). 
Level IV 
evidence: Cohort 
design 
Small sample 
population 
Hard to 
generalize results 
with small 
sample. 
No, limited data 
supportive to 
efficiently support 
the data provided 
by the two 
participants. 
However, this 
does spark the 
need for further 
research if results 
can be 
demonstrated 
again.  
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Lithgow, K., Edwards, A., 
& Rabi, D. (2017). 
Smartphone app Use for 
diabetes management: 
Evaluating patient 
perspectives. JMIR 
Diabetes, 2(1), 2. 
doi:10.2196/diabetes.664
3 
The purpose of 
the study was to 
gain insight into 
patient 
experiences 
related to the 
usage of 
smartphone usage 
for diabetes 
management 
(Lithgow, 
Edwards, & Rabi, 
2017).  
N=12 
questionnaire 
survey of app 
usage diagnosed 
with T1DM. 7 
men and 5 
women. 
Non-randomized, 
purposive 
sampling 
strategy.   
Participants 
displayed the 
interest in having 
more apps with 
more features to 
help manage their 
diabetes.  Current 
app technology 
must be geared 
towards catering 
to patient’s needs 
(Lithgow et al., 
2017). 
Level III: Quasi 
experimental  
Lack of 
generality and 
cannot be applied 
to larger 
population 
(Lithgow et al., 
2017). 
Yes, this study 
shows patients 
want more 
technological 
apps geared 
towards 
supporting self-
management. 
Mallow, J. A., Theeke, L. 
A., Barnes, E. R., 
Whetsel, T., & Mallow, 
B. K. (2014). Using 
mHealth tools to improve 
rural diabetes care guided 
by the chronic care 
model. Online Journal 
Rural Health Care 
Nursing, 14(1), 43-65. 
doi:10.14574/ojrnhc.v14i
1.27 
The purpose of 
this study 
mHealth mobile 
technology be 
used effectively 
as an intervention 
improve chronic 
disease 
management 
(Mallow, Theeke, 
Barnes, Whetsel, 
& Mallow, 2014). 
 
N= 23 articles 
that meet 
inclusive criteria. 
 
256 articles 
screened 
Systematic 
Review 
Mobile app 
utilization in the 
underserved 
patient population 
can improve 
patient outcomes 
drastically.  A 
recommendation 
to incorporate 
further mobile 
technology in the 
healthcare model 
is recommended 
(Mallow et al., 
2014). 
Level I: 
Systematic 
Review 
Limitations of 
this study consist 
of studying 
mobile apps with 
only providers 
who endorse 
outside traditional 
care.  It was hard 
to make 
generalization for 
effectiveness if 
the provider did 
not support app 
utilization. 
Yes, this study 
supports the 
mobile 
technology as the 
future in 
healthcare.  The 
results endorse 
cost effectiveness, 
improving 
healthcare access, 
and overall 
improving patient 
outcomes. 
Schmocker, K. S., Zwahlen, 
F. S., & Denecke, K. 
(2018). Mobile app for 
simplifying life with 
diabetes: Technical 
description and usability 
study of GlucoMan. JMIR 
Publications, 3(1), e6. 
doi:10.2196/diabetes.816
0 
 
Develop a mobile 
app that provides 
secure collection 
data and stores 
vital diabetic 
information such 
as (blood sugars, 
hemoglobin A1c) 
with provider 
access to patient 
information. 
N- 6 app users 
 
2= T2DM 
4= Non-T2DM 
Non-randomized 
control trail 
Data collection 
for patients with 
T2DM can be 
supported via the 
utilization of 
mobile apps.  
These mobile 
apps provide 
patients the 
ability to monitor 
relevant 
parameters set by 
their providers.  
Level III: Quasi 
Experiment 
Limitations of 
this study consist 
of limited study 
participants.  
Hard to apply 
study results for 
larger population.  
Yes, despite 
limitations of this 
study, still 
supported that 
data can be safely 
streamed securely 
to providers via 
mobile apps.  
Providing a great 
tool for providers 
and convenience 
for app users.  
Schreier, G., Eckman, H., 
Hayn, D., Kriener, K., 
Kastner, P., & Lovell, N. 
The purpose of 
this study was to 
see if the mobile 
N=403 patients 
enrolled in the 
program 
Non-randomized 
control trial  
The results 
obtained in this 
study of patients 
Level III: Quasi 
Experimental  
Limitations of 
this study were 
based on the user 
Yes, cautiously. 
This study 
supported both 
MOBILE-BASED APP FOR TYPE 2 DIABETES MANAGEMENT 74 
(2013). Web versus app – 
compliance of patients in 
a telehealth diabetes 
management 
programming two 
different technologies. 
Journal of Telemedicine 
& Telecare, 18(8), 476-
480. 
doi:10.1258/jtt.2012.GTH
112 
 
app could support 
physicians 
achieve 
sustainable 
lifestyle 
modifications, 
tailor therapy to 
individual needs, 
increased therapy 
adherence and 
safety (Schreier 
et al., 2013). 
N=291 app 
controlled 
N=109 Web 
controlled  
in a telehealth 
diabetes 
management 
program revealed 
a significantly 
higher 
compliance rate 
for patients using 
a mobile phone 
and NFC-based 
application user 
interface to 
acquire and 
transmit their 
health data than 
for patients 
predominantly 
submitting data 
via a web-
browser (Schreier 
et al., 2013). 
preference, and 
overall resources 
for each 
participant.  
web and mobile 
apps improving 
self-care 
management of 
diabetes.  Data 
was not 
supportive of app 
usage alone.  
Shadid, A., Mahar, S. A., 
Shaikh, S., & Shaikh, Z. 
U. (2015). Mobile phone 
intervention to improve 
diabetes care in rural 
areas of Pakistan: A 
randomized controlled 
trial. Journal College 
Physician Pakistan, 
25(3), 166-171. 
doi:03.2015/JCPSP.1661
71 
 
To determine the 
effect of mobile 
phone 
intervention on 
HbA1c in type-2 
Diabetes Mellitus 
(DM) patients 
living in rural 
areas of Pakistan 
(Shadid, Mahar, 
Shaikh, & 
Shaikh., 2015). 
 
 
N=400 
N=200 controlled 
N=200 non-
controlled group 
Randomized 
Control Trial 
Patients 
in intervention 
group showed 
improvement (p < 
0.001) in 
following diet 
plan from 17.3% 
at baseline to 
43.6% at endline, 
however, the 
control group 
showed 
insignificant 
increase 
(p=0.522) from 
13.6% at baseline 
to 15.9% at 
endline. 
Intervention 
group (RR = 
2.71, 95% CI = 
1.18 - 6.40) 
showed 
significant 
Level 3: 
Quasi 
Experimental  
Patients were 
followed for 4 
months. It is very 
difficult to 
change certain 
parameters like 
BMI in such short 
time duration. 
Only patients 
presenting to one 
hospital in 
Karachi and 
patients who 
were from two 
rural regions of 
Pakistan were 
studied due to 
defined 
catchment area of 
the hospital 
(Shadid et al., 
2015). 
Yes, despite the 
current limitations 
associated with 
the study.  There 
was a significant 
amount of 
improvement with 
the utilization of 
mobile app 
intervention.  
Enough to 
endorse further 
studies that utilize 
mobile apps as 
complementary 
treatments for 
T2DM.  
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positive 
association with 
normalization of 
HbA1c levels 
(Shadid et al., 
2015) 
Shah, V. N., & Garg, S. K. 
(2015). Managing 
diabetes in the digital age. 
Clinical Diabetes and 
Endocrinology, 1(16), 20-
36. doi:10.1186/s40842-
015-0016-2 
A systematic 
review was 
conducted to 
review new 
digital 
technologies in 
diabetes self-care 
management and 
address potential 
challenges (Shah 
& Garg, 2015).  
N=22 mobile 
apps 
 
All apps endorse 
selfcare 
management 
techniques for 
patients 
Systematic 
Review 
This study 
supports that 
overcoming 
barriers 
associated with 
mobile 
technology for 
self-care 
improvement of 
T2DM is 
promising (Shah 
& Garg, 2015). 
 
Level I:  
Systematic 
Review 
Limitations of 
this study consist 
of large 
healthcare 
systems that can 
not overcome 
barriers with 
incorporating 
mobile 
technology into 
healthcare (Shah 
& Garg, 2015).  
Yes, this study 
effectively 
addressing 
various barriers to 
incorporating 
mobile 
technology into 
diabetic 
management in 
the digital age.  
Whitehead, L., & Seaton, P. 
(2016). The effectiveness 
of self-management 
mobile phone and tablet 
apps in long-term 
condition management: A 
systematic review. JMIR, 
18(5), 97-108. 
doi:10.2196/jmir.4883 
A systematic was 
conducted review 
and assess the 
effectiveness 
of mobile phone 
and tablet apps in 
self-management 
of key symptoms 
of long-term 
conditions 
(Whitehead & 
Seaton, 2016) 
9 papers we 
reviewed, 6 of the 
interventions 
demonstrated a 
statistically 
significant 
improvement in 
the primary 
measure of 
clinical outcome. 
Participants 
ranged from 48 to 
288 per year 
(Whitehead & 
Seaton, 2016).   
Systematic 
Review 
The evidence 
indicates the 
potential of apps 
in improving 
symptom 
management 
through self-
management 
interventions 
(Whitehead & 
Seaton, 2016).  
Level I: 
Systematic 
Review 
Two selected 
apps only during 
the selected time 
frame. More 
rigorous research 
needed on larger 
scale to improve 
research results.  
Yes, this study 
supports various 
trials that have 
improved patient 
outcomes with the  
Incorporation of 
mobile apps.  
Yang, S., Kong, W., Hsue, 
C., Fish, A. F., Chen, Y., 
Guo, X., ... Anderson, R. 
(2016). Knowledge of 
A1c predicts diabetes 
self-management and A1c 
level among Chinese 
patients with type 2 
diabetes. PLoS One, 
11(3). 
The study was 
designed to 
assess the 
knowledge of 
A1c and its 
relationships with 
diabetes self-
management and 
A1c level among 
Chinese patients 
A study sample 
of 5957 patients 
was utilized. 
3040, 1247, and 
1670 were from 
Eastern, Central, 
and Western 
China (Yang et 
al., 2016). 
Cross-Sectional 
study 
The results also 
show that there 
was a correlation 
between 
understanding of 
A1c, diabetes 
self-management 
behavior and 
glycemic control. 
This implies that 
Level IV:  Cross-
sectional study 
Limited factor 
assessment of 
hemoglobin A1c 
control.  
Limited 
questionnaire   
Yes, provides a 
large sample with 
the correlation 
between increased 
education and 
improved A1c. 
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Clinical Question: In underserved patients with T2DM, does utilization of a Diabetes App, compared to previous self-care 
management and clinic education, lower the Hemoglobin A1c over a three-month period? 
*Note: Melnyk’s Level of Evidence (LOE) Pyramid is required for appraising the level of evidence. 
  
doi:10.1371/journal.pone.
0150753 
 
with type 2 
diabetes (Yang et 
al., 2016).  
a good 
understanding of 
A1c can improve 
clinical 
outcomes, such as 
FBG, 2hPPG, and 
A1c. Those with 
better 
understanding 
understood their 
A1c performed 
better self-
management 
behavior (Yang et 
al., 2016).  
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Appendix B 
Permission to Use and/or Reproduce The Iowa Model (1998) 
Kimberly Jordan - University of Iowa Hospitals and Clinics <noreply@qualtrics-survey.com> 
Mon 11/19/2018, 3:33 AM 
To: 
Smith, Fred <fsmith23@liberty.edu> 
You have permission, as requested today, to review and/or reproduce The Iowa Model of Evidence-Based Practice to Promote Quality 
Care (Revised 1998).  Click the link below to open.  
 
The Iowa Model of Evidence-Based Practice to Promote Quality Care (Revised 1998)  
 
Copyright is retained by University of Iowa Hospitals and Clinics. Permission is not granted for placing on the internet.  
 
Citation: Titler, M. G., Kleiber, C., Steelman, V. J., Rakel, B.A., Budreau, G., Everett, L. Q., ...Goode, C. J. (2001). The Iowa model 
of evidence-based practice to promote quality care. Critical Care Nursing Clinics of North America, 13(4), 497-509.  
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In written material, please add the following statement:  
Used/reprinted with permission from the University of Iowa Hospitals and Clinics, copyright 1998. For permission to use or 
reproduce, please contact the University of Iowa Hospitals and Clinics at 319-384-9098 . 
   
Please contact UIHCNursingResearchandEBP@uiowa.edu or 319-384-9098 with questions.  
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Appendix C 
Diabetic Self-Questionnaire 
Please circle the following questions below according to your current lifestyle 
1= strongly disagree 
2= disagree 
3= neutral (neither agree or disagree) 
4= agree 
5= strongly agree 
 
1. I check my blood sugar level at home at least once a day 
1= strongly disagree   2= disagree   3= neutral (neither agree or disagree)   4= agree   5= strongly agree 
2. I record my blood sugar level at least once daily. 
1= strongly disagree   2= disagree   3= neutral (neither agree or disagree)   4= agree   5= strongly agree 
3. I take my diabetes medication at home as prescribed by my doctor or nurse practitioner.   
1= strongly disagree   2= disagree   3= neutral (neither agree or disagree)   4= agree   5= strongly agree 
4. I follow the diabetic dietary recommendations given to me by my diabetic educator, doctor, or nurse practitioner.    
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1= strongly disagree   2= disagree   3= neutral (neither agree or disagree)   4= agree   5= strongly agree 
5. I choose foods to eat that makes it easy to achieve good blood sugar levels. 
1= strongly disagree   2= disagree   3= neutral (neither agree or disagree)   4= agree   5= strongly agree 
6. I plan my meals. 
 1= strongly disagree   2= disagree   3= neutral (neither agree or disagree)   4= agree   5= strongly agree 
7. I use healthy diabetic recipes to prepare my meals. 
1= strongly disagree   2= disagree   3= neutral (neither agree or disagree)   4= agree   5= strongly agree 
8. I exercise 15 to 30 minutes at least 3 times a week.  
1= strongly disagree   2= disagree   3= neutral (neither agree or disagree)   4= agree   5= strongly agree 
9. I keep all of the appointments recommended for my diabetes treatment.  
1= strongly disagree   2= disagree   3= neutral (neither agree or disagree)   4= agree   5= strongly agree 
10. I use a diabetes app to help educate me on diabetes and health issues associated with diabetes.       
1= strongly disagree   2= disagree   3= neutral (neither agree or disagree)   4= agree   5= strongly agree  
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Appendix D 
Letter of Support for the Site 
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Appendix E 
Collaborative Institutional Training Initiative Certificate of Successful Completion 
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Appendix F 
IRB Approval 
March 14, 2019  
  
Fred Allen Smith Jr  
IRB Approval 3686.031419: Mobile-Based Technology App Used to Improve Self-Care Management of Patients with 
Type 2 Diabetes Mellitus  
  
Dear Fred Allen Smith Jr,  
  
We are pleased to inform you that your study has been approved by the Liberty University IRB. This approval is 
extended to you for one year from the date provided above with your protocol number. If data collection proceeds past 
one year or if you make changes in the methodology as it pertains to human subjects, you must submit an appropriate 
update form to the IRB. The forms for these cases were attached to your approval email.  
  
Your study falls under the expedited review category (45 CFR 46.110), which is applicable to specific, minimal risk 
studies and minor changes to approved studies for the following reason(s):  
  
2. Collection of blood samples by finger stick, heel stick, ear stick, or venipuncture as follows:   
a. from healthy, nonpregnant adults who weigh at least 110 pounds. For these subjects, the amounts drawn 
may not exceed 550 ml in an 8 week period and collection may not occur more frequently than 2 times per 
week; or  
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b. from other adults and children [2], considering the age, weight, and health of the subjects, the collection 
procedure, the amount of blood to be collected, and the frequency with which it will be collected. For these 
subjects, the amount drawn may not exceed the lesser of 50 ml or 3 ml per kg in an 8 week period and 
collection may not occur more frequently than 2 times per week.  
  
7. Research on individual or group characteristics or behavior (including, but not limited to, research on perception, 
cognition, motivation, identity, language, communication, cultural beliefs or practices, and social behavior) or research 
employing survey, interview, oral history, focus group, program evaluation, human factors evaluation, or quality 
assurance methodologies. (NOTE: Some research in this category may be exempt from the HHS regulations for the 
protection of human subjects. 45 CFR 46.101(b)(2) and (b)(3). This listing refers only to research that is not exempt.)  
  
Thank you for your cooperation with the IRB, and we wish you well with your research project.   
  
Sincerely,  
 
G. Michele Baker, MA, CIP  
Administrative Chair of Institutional Research  
Research Ethics Office  
 
Liberty University | Training Champions for Christ since 1971 
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Appendix G 
Consent Form 
The Liberty University Institutional Review Board has approved this document for use from 3/14/2019 to 3/13/2020 Protocol # 
3686.031419 
CONSENT FORM 
MOBILE-BASED TECHNOLOGY APP USED TO IMRPOVE SELF-CARE MANAGEMENT OF PATIENTS WITH TYPE 2 
DIABETES MELLITUS 
Fred Smith Jr 
Liberty University 
School of Nursing 
 
You are invited to participate in a scholarly research project. You were selected as a possible participant because you are between the 
ages of 19-70, have type two diabetes mellitus (T2DM) for greater than six months, English speaking, have access to an Android or 
iOS device, and have had a referral to the diabetic educator within the last 12 months.  Please read this consent form and ask any 
questions you may have before agreeing to be in the study.  Fred Smith Jr, a doctoral candidate in the School of Nursing at Liberty 
University, is conducting this scholarly project.  
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Background Information: The purpose of this scholarly project is to determine if the utilization of the Diabetes app will decrease the 
hemoglobin A1c in patients diagnosed with T2DM in the underserved patient population.  Furthermore, the development of the 
Diabetes app aims to provide the underserved patient population with full-time access to improve self-care management techniques 
and diabetic education to improve their hemoglobin A1c. 
 
Procedures: If you agree to be in this study, I would ask you to do the following things: 
1. During your normal appointment, you will be asked to have your hemoglobin A1c drawn, fill out a 10-question diabetic 
questionnaire, demographic form, and be provided access to the custom Diabetes app. The app is FREE of charge to all 
participants in this study.  Estimated time to complete this procedure is 30 minutes.   
2. Participants will be provided a detailed explanation of the Diabetes app in person during their first hemoglobin A1c draw by 
the project team leader (Fred Smith). Participants will receive two push notifications each day, one at 8am and one at 5pm, 
with helpful self-care management tips. Participants will be asked to utilize the Diabetes app daily during a three-month 
period. Participants are asked to utilize the Diabetes app daily during the three-month study period.   
3. Following the three-month window participants will take the same 10 question diabetes questionnaire again and have their 
hemoglobin A1c drawn during their normal three-month chronic care appointment at BFP.  Estimated time to complete this 
procedure should take about 20 minutes.  
4. Data will be pulled from each user’s activity during the three-month period. User data studied will consist of screen time of 
each user and actions within the app.  
 
Risks: The risks involved in this study are minimal, which means they are equal to the risks you would encounter in everyday life. 
 
Benefits: The Diabetes app will serve as an education hub for all study participants.  The Diabetes app will consist of dietary food 
options, recommended exercise regimens, blood sugar log, diabetic education in congruence with the American Diabetes Association, 
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and self-care techniques for diabetes management.   In addition, the goals of increased self-care management should improve patient’s 
hemoglobin A1c outside of traditional diabetic educational methods.  Increased availability of disease management techniques endorse 
better chronic disease management.  Better management of diabetes prevents further associated complications of uncontrolled diabetes 
such as diabetic neuropathy, diabetic retinopathy, heart disease, kidney disease, and overall shorter lifespan.  
 
Benefits to society may include: Technology supports self-care management by providing patients the ability to have blood glucose 
monitoring, dietary recommendations, medication adherence, and user platform discussion forums.  The utilization of mobile app 
technology improves barriers to healthcare access, improves patient education, and increases patient exposure to self-care 
management techniques.  Healthcare providers should incorporate the utilization of mobile-based technology to effectively manage 
T2DM. Better short term and long-term management of T2DM will reduce associated costs of complications with ineffective T2DM 
management.  Potentially an estimated 327 billion dollars could be saved in estimated healthcare costs associated with T2DM 
complications.  
 
Compensation: Participants may be compensated for participating in this study.  All study participants will have the opportunity to 
have their name placed in a drawing to win a 19inch television.  This number of times each participant is based on who has the highest 
app utilization, fastest study enrollment, and overall highest hemoglobin A1c decrease (three ways to boost entry count). Every day 
participants that login the Diabetes app they will be given one entry, for a maximum of 90 entries (1 entry potentially each day for 90 
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days).  Participants that sign consent within three days will receive 50 additional entries to their grand total.  In addition, the 
participant with the overall highest hemoglobin A1c decrease will receive an additional 100 entries at the end of the study. All study 
participants based on the previously mentioned criteria will have their entries totaled and randomly selected at the end of the study 
during a drawing. The winning participant must complete the entire study time of three months and must complete all before and after 
questionnaires for the study to receive the 19-inch television.   
 
Confidentiality: The records of this study will be kept private. In any sort of report or presentation I might publish, I will not include 
any information that will make it impossible to identify subjects.  Any information gathered from the app utilization will be protected 
under encrypted codes within the app (private app). All information will be encrypted with no personal information related to study 
participants. There will be no interactions with other users. All feedback from potential users will be sent directly to the project team 
leader email or cell phone. The Diabetes app is exclusively available to only participants associated with this study. Research records 
will be stored securely, and only the researcher will have access to the records.  I may share the data I collect from you for use in 
future studies or with other researchers; if I share the data that I collect about you, I will remove any information that could identify 
you, if applicable, before I share the data.  
 
 Participants will be assigned a randomized number.  
 Data will be stored on a password locked computer and may be used in future presentations. After three years, all electronic 
records will be deleted in accordance with federal law. 
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 All data collected and gathered from the Diabetes app will be stored and secured with an encrypted login and private secure 
database. This app is made private, and only available to involved study particpants.  Data will be sent to previously mentioned 
above password locked computer and may be used for future presentations. After three years, all electronic records will be 
deleted in accordance with federal law. 
 
Voluntary Nature of the Study: Participation in this study is voluntary. Your decision whether or not to participate will not affect 
your current or future relations with Liberty University or Bassett Family Practice. If you decide to participate, you are free to not 
answer any question or withdraw at any time.  
 
How to Withdraw from the Study: If you choose to withdraw from the study, please contact the researcher at the email 
address/phone number included in the next paragraph. Should you choose to withdraw, data collected from you will be destroyed 
immediately and will not be included in this study.  
 
Contacts and Questions: The researcher conducting this study is Fred Smith Jr. You may ask any questions you have now. If you 
have questions later, you are encouraged to contact him at 336-837-5190 or fsmith23@liberty.edu. You may also contact the 
researcher’s faculty chair, Dr. Moore, at vbmoore@liberty.edu.  
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If you have any questions or concerns regarding this study and would like to talk to someone other than the researcher, you are 
encouraged to contact the Institutional Review Board, 1971 University Blvd., Green Hall Ste. 2845, Lynchburg, VA 24515 or email 
at irb@liberty.edu.   
 
Please notify the researcher if you would like a copy of this information for your records. 
 
Statement of Consent: I have read and understood the above information. I have asked questions and have received answers. I 
consent to participate in the study. 
 
 
______________________________________________________________________________ 
Signature of Participant        Date 
 
 
______________________________________________________________________________ 
Signature of Investigator        Date 
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Appendix H 
Demographics Questionnaire  
Please answer the following questions below: (Any section may be left blank) 
 
Age: 
Sex: 
Race: 
Highest level of education: 
Household income: 
Years of diabetes:  
Home diet:                        
Current diabetic medication: 
 
 
 
 
 
All information is kept confidential and encrypted   
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Appendix I 
Likert Scale Ranking Score Diabetes Questionnaire  
Total score as follows: 
20 or below Bad (high risk complications) 
25-20 Poor 
30-25 Below-Average 
30-40 Average 
40-45 Good 
45-50 Great 
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Appendix J 
Instructions for Diabetes App: 
 
1. Please turn on phone 
2. Please locate markets for your service provider (App store for iOS users), (Android marketplace for Android 
users) 
3. Please type in the search engine “Diabetes app 
4. Please locate free version 
5. Login with user email and create password 
a. For Apple users you may utilize your Face ID to sign in for your password, or thumbprint on older models 
once your password is created 
b. For Android users you will have to set up with an email and password. 
6. Once logged in you will be taken to the home screen.  Please click the in app mobile widget named “Welcome” 
a. Inside the welcome function you will watch an introductory video, purpose of this scholarly project, and 
will receive step by step instructions on how to use each function from team leader Fred Smith Jr DNP 
candidate.  
7. If you encounter any problems with gaining access to the welcome screen, please contact the app developer 
Fred Smith. 
a. Contact any time with questions at 336-837-5190 or email any questions to fsmith23@liberty.edu.  You will 
receive a response within 24-hours 
8. I hope you enjoy this app!  
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Appendix K 
Timeline of the Scholarly Project 
Completion 
Date 
Planning Pre-Implementation Implementation Evaluation 
7/31/2018 Meet with Scholarly 
project chair to present 
idea and project 
development 
   
8/30/2018 Receive approval from 
scholarly project chair, 
then identify key stake 
holders individually to 
obtain their support and 
organization endorsement. 
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8/30/2018 First meeting with clinical 
director and organization 
providers to present ideas 
for project. 
   
9/30/2018 Receive verbal 
endorsement of letter of 
support from Bassett 
Family Practice clinical 
director.  
   
10/30/2018 Began and draft pre-
proposal for IRB 
submission 
   
11/1/2018  Pre-screen 60 participants 
who meet inclusive criteria 
for the project 
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12/15/2018  Submit pre-proposal to 
scholarly project chair  
  
1/16/2019  Perform mini-presentation 
to scholarly project chair  
  
1/20/2019  Submit IRB application    
2/20/2019  Develop app with Appy 
Pie software  
  
2/20/2019-
3/1/2019 
 Receive IRB approval    
3/1/2019  Develop Diabetes App for 
Android and iOS platforms 
  
3/15/2019  Launch 5 beta testers of 
app 
  
2/20/2019- 
3/20/2019 
  Obtain consent for 60 
participants, and instructions on 
how to utilize mobile app, 
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implement diabetes 
questionnaire and 
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3/25/2019   Implement utilization of 
Diabetes app for scholarly 
project for three-month period 
 
3/25/2019   Start two-push notifications 
daily for enrolled participants 
during three-month period  
 
6/25/2019   Conclude three-month scholarly 
project Diabetes app and 
distribute post survey.  
 
6/25/2019    Utilize SPSS 
software to analyze 
data, prepare 
presentation 
7/15/2019- 
8/1/19 
   Present data  
